Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
Winter 1-1-2012

Natural Killer Cell Recruitment and Activation Following
Orthopoxviral Infection
Melissa Anne Pak-Wittel
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Pak-Wittel, Melissa Anne, "Natural Killer Cell Recruitment and Activation Following Orthopoxviral Infection"
(2012). All Theses and Dissertations (ETDs). 1016.
https://openscholarship.wustl.edu/etd/1016

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Division of Biology and Biomedical Sciences
Immunology

Dissertation Examination Committee:
Wayne M. Yokoyama, Chair
John P. Atkinson
Marco Colonna
Anthony R. French
Deborah J. Lenschow
Emil R. Unanue

Natural Killer Cell Recruitment and Activation Following Orthopoxviral Infection
by
Melissa A. Pak-Wittel

A dissertation presented to the
Graduate School of Arts and Sciences
of Washington University in
partial fulfillment of the
requirements for the degree of
Doctor of Philosophy

December 2012
Saint Louis, Missouri

TABLE OF CONTENTS
Page
iii

LIST OF FIGURES AND TABLES
LIST OF ABBREVIATIONS

vi

ACKNOWLEDGEMENTS

viii

ABSTRACT

x

CHAPTER 1:

Introduction

1

CHAPTER 2:

Materials and Methods

12

CHAPTER 3:

Host response to CPXV footpad infection

21

CHAPTER 4:

The mechanism of NK cell recruitment

46

CHAPTER 5:

Up-stream requirements for NK cell recruitment and viral
burden

68

CHAPTER 6:

Comparison of CPXV & VV footpad infection

103

CHAPTER 7:

CPXV mediated inhibition of NK cell activation

127

CHATPER 8:

Conclusions and Future Directions

164

REFERENCES

177

ii

LIST OF FIGURES AND TABLES
Page
CHAPTER 2
Table 1.

Quantitative PCR primer/probe sets.

19

CHAPTER 3
Figure 1.

Morbidity and mortality following CPXV footpad infection.

32

Figure 2.

Kinetics of innate lymphocyte expansion following CPXV
footpad infection.

34

Figure 3.

Kinetics of adaptive lymphocyte expansion following CPXV
footpad infection.

36

Figure 4.

Kinetics of NK cell expansion following CPXV footpad
infection.

38

Figure 5.

CPXV titers following footpad inoculation.

40

Figure 6.

Systemic NK cell depletion leads to increased viral burden in
some but not all organs following early footpad inoculation.

42

Figure 7.

CPXV persists longer in mice that were systemically depleted of
NK cells.

44

Expansion of the NK cell population cannot fully be explained
by in situ proliferation.

56

Figure 9.

NK cells isolated from the draining LN following CPXV
infection phenocopy surface staining of splenically derived NK
cells.

58

Figure 10.

Draining LN NK cells do not express markers of thymic NK
cells.

60

Figure 11.

NK expansion in the draining LN is pertussis toxin sensitive
following CPXV infection.

62

Figure 12.

Inflammatory chemokine transcripts are up-regulated following
CPXV infection.

64

Figure 13.

NK cell recruitment occurs in the absence of CCR2 and CCR5
but intrinsically requires CXCR3 expression following CPXV
infection.

66

CHAPTER 4
Figure 8.

iii

CHAPTER 5
Figure 14.

IFN-! is required for NK cell recruitment and inflammatory
chemokine expression
CCR7 is extrinsically required for NK cell recruitment to the
draining LN following CPXV infection.

83

Figure 16.

NK cell recruitment is defective in CPXV infected CD11c-DTR
transgenic mice.

87

Figure 17.

Inconsistencies in CCR7-deficient mice.

89

Figure 18.

BMDCs do not complement NK cell recruitment defects seen in
CD11c-DTR transgenic mice following CPXV infection.

91

Figure 19.

BATF3 deficiency does not affect NK cell trafficking following
CPXV infection.

93

Figure 20.

Macrophage depletion leads to decreased lymphocyte
recruitment.

95

Figure 21.

Inflammatory chemokine transcripts are unaffected by
macrophage depletion.

97

Figure 22.

NK cells control CPXV replication in CXCR3-deficient mice.

99

Figure 23.

Macrophage depletion does not impact CPXV replication.

101

VV establishes infection in the draining LN and spleen
following footpad inoculation.

113

Figure 25.

Comparative kinetics of innate and adaptive lymphocyte
expansion following CPXV or VV footpad infection.

115

Figure 26.

NK cells isolated from the draining LN following VV infection
express markers of splenic but not thymic NK cell subsets.

117

Figure 27.

NK expansion in the draining LN is pertussis toxin sensitive
following VV infection.

119

Figure 28.

Inflammatory chemokine transcripts are up-regulated following
VV infection.

121

Figure 29.

NK cell recruitment occurs in the absence of CCR2 and CCR5
but intrinsically requires CXCR3 expression following VV
infection.

123

Figure 30.

BMDCs do not complement NK cell recruitment defects seen in

125

Figure 15.

CHAPTER 6
Figure 24.

iv

85

CD11c-DTR transgenic mice following VV infection.
CHAPTER 7
Figure 31.

CPXV infection inhibited production of IFN-! by NK cell
recruited to the draining LN.

140

Figure 32.

VV infection but not CPXV infection stimulated NK production
of IFN-! in a dose dependent manner.

142

Figure 33.

Kinetic analysis of cytokine expression in the draining LN
following CPXV and VV infection.

144

Figure 34.

Kinetic analysis of NK cell expression of surface activation
molecules following CPXV or VV infection.

146

Figure 35.

NK cells produce granzyme B following CPXV and VV
infection.

148

Figure 36.

NK cells do not produce IFN-! following co-infection with
CPXV and VV.

150

Figure 37.

Inhibition of NK cell IFN-! production can be overcome.

152

Table 2.

Unique CPXV encoded ORFs.

154

Figure 38.

The inhibition of IFN-! production by NK cells is unaffected in
the absence of CPXV012, CPXV018 and CPXV203.

156

Figure 39.

The A587 mutant inhibits NK cell IFN-! production.

158

Figure 40.

NK cells activation is partially restored following infection with
the A518 mutant.

160

Figure 41.

CPXV inhibition of NK cell IFN-! production is control by
multiple ORFs.

162

v

LIST OF ABBREVIATIONS
CFSE

carboxyfluorescein diacetate

CPXV

Cowpox virus

DCs

Dendritic cells

DNA

deoxyribonucleic acid

dpi

days post infection

ECTV

Ectromelia virus

FLT-3

FMS-related tyrosine kinase-3 ligand

GCPR

g-coupled protein receptor

GDP/GTP

guanosine diphosphate / guanosine triphosphate

GMCSF

granulocyte macophage colony-stimulating factor

g-protein

guanine nucleotide binding protein

IFN

inteferon

IL

interleukin

IN

intranasal

IP

intraperitoneal

IV

intravenous

kb

kilobase

LN

lymph node

MDA 5

melanoma differentiation associate gene 5

MHC I

major histocompatibility class I

mL

milliliter

ms

mouse

MVA

modified vaccinia Ankara
vi

NK

natural killer

ORF

open reading frame

PBS

phosphate buffered solution

PMA

phorbol myristle acetate

polyI:C

polyinosinic:polycytidylic acid

PRR

pattern recognition receptor

RIG I

retinoic acid inducible receptors

RNA

ribonucleic acid

TNF"

tumor necrosis factor "

#g

microgram

#l

microliter

VARV

Variola virus

VV

Vaccinia virus

vii

Acknowledgements
Herein I would like to acknowledge the many people who have mentored and
encouraged me during my thesis work. First I would like to thank Wayne Yokoyama for
supporting me, both financially and scientifically, during my graduate career. Inasmuch
as Wayne has allowed me freedom while still providing guidance, I have learned to think
more critically, proceed cautiously and interpret my data systemically.
I would also like to extend my sincere thanks to my thesis committee: Drs. John
Atkinson, Marco Colonna, Tony French, Debbie Lenschow and Emil Unanue. Their
critiques and suggestions challenged me to grow, be more skeptical and have made me a
better scientist. I appreciate the enthusiasm and support that they have provided during
my graduate education and training.
Fellow members of the Yokoyama lab also deserve many thanks. In addition to
mentoring me, they have provided scientific and personal support throughout my
endeavors. In particular, I would like to acknowledge Dorothy Sojka for providing
guidance and contributing to my work, and Beatrice Plougastel and Bijal Parikh who
always provided insight, discussion and helped me overcome scientific hurdles. I must
also thank Liping Yang and Josh Rivenbark; my experiments could not have been done
without their kind assistance. I would also like to acknowledge Jennifer Laurent, Lorraine
Schwartz, Tammy Derleth and Darryl Higuchi for all their help ensuring my project ran
smoothly. Past and present members of the lab including Jimmy Ma, Melissa Berrien,
Tammy Cheng, Paul Klekotka, Peter Keyel, Joe Wahle, John Sunwoo, Stephen Ferris,
Megan Cooper, Jian Gao, Syste Piersma, Diana Beckman, Samantha Taffner, Maria
Gainey, and Takashi Ebihara have provided a stimulating and fun environment to learn
and work.
viii

I would also like to acknowledge my fellow graduate students in the lab who have
been not just co-workers, but true friends. I thank Claudia Vargas and Julie (Elliott)
Chase who were always willing to listen. Thanks also to Minji Byun, who taught me so
much about the cowpox virus system, to Helena Jonsson, whose interest always
challenged me, and thanks to Chris Affolter, who has been a pillar of support through
many challenges.
The Washington University community has been a wonderful family during my
graduate career and I have made many great friends here. I am grateful for their support,
shared advice, protocols and reagents. In particular, I would like to thank Beverly (Illian)
Strong, Danielle Atibalentja, Anja Fuchs, Monica (Walker) Drylewicz, Clara Moon,
Holly (Smith) Akilesh and Elizabeth Miller.
My family and friends from California have also been a source of encouragement
and support throughout the years. I want to thank my parents, grandparents, brothers and
sister-in-law for believing in and supporting me throughout my entire education. In
particular, my younger brother, Arthur, and his wife, Julie, were graduate students at the
same time and have commiserated with me and provided helpful advice. I would also like
to acknowledge my best friends: Freecia Wang, Charlene Betts-Ng and Robin Carle, who
always reminded me that I could do this.
Finally, I would like to acknowledge my husband, Gregory Wittel. He has
celebrated the high points and carried me through the low points. His belief in my ability
as a scientist has been constant and a source of motivation throughout all these years.

ix

ABSTRACT OF THE DISSERTATION
Natural Killer Cell Recruitment and Activation Following Orthopoxviral Infection
by
Melissa A. Pak-Wittel
Doctor of Philosophy in Biology and Biomedical Sciences
Immunology
Washington University in St Louis, 2012
Professor Wayne M. Yokoyama, Chairperson
The orthopoxviridae are large, complex DNA viruses with important historical
and clinical significance. Members of this genus encode numerous proteins known to
subvert the immune response to infection, providing a useful system to probe required
host responses for resistance and survival. Natural killer (NK) cells provide an essential
innate response to infection through direct lysis of infected cells and cytokine production.
The innate anti-viral response following infection is associated with NK cell population
expansion in draining LNs, where they are normally a rare population. We have
identified mechanisms underlying NK cell expansion following orthopoxviral infection
and have examined viral inhibition of the NK cell-mediated host response.
Since close contact with cowpox virus (CPXV), a natural pathogen of rodents,
causes zoonotic infections in humans, we employed a footpad model of infection in mice
to determine the requirement of NK cells for resistance to orthopoxviral infection.
Systemic depletion of NK cells prior to CPXV infection resulted in increased viral
replication and systemic dissemination. Recruitment of NK cells to the draining LN was
pertussis toxin sensitive indicating chemokine receptor dependence. Candidate
chemokine receptors were identified by comprehensive analysis of chemokine mRNA
x

expression in the draining LN in conjunction with chemokine receptor expression on NK
cells. We determined that CXCR3 was intrinsically required for NK cell recruitment to
the draining LN in an interferon-!# (IFN-!) dependent manner. Additionally, a nonoverlapping requirement for subcapsular sinus macrophages was required for NK cell
recruitment.
CPXV inhibited full maturation of NK cells leading to incomplete activation
following infection. We found that NK cells recruited to the draining LN did not produce
IFN-! or up-regulate surface activation markers. The inhibition of NK cell production of
IFN-! was CPXV specific, multifactorial and complex. Despite this phenotype, cytotoxic
function of NK cells was preserved through uninhibited production of granzyme B. We
have demonstrated that the innate response to CPXV infection induces chemokinemediated recruitment of NK cells to the draining LN where they limit replication and
dissemination despite specific inhibition by CPXV.
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CHAPTER 1:
Introduction

Orthopoxviruses, Cross Protective Vaccination and Zoonotic Infections
Orthopoxviruses are large, complex DNA viruses whose genus includes
historically and clinically important viruses. Among these is variola virus (VARV), the
causative agent of smallpox infection, which had devastating consequences on the human
population due to its significant morbidity and morality (1). Cross-protection conferred
by another orthopoxvirus, vaccinia virus (VV), allowed eradication of naturally occurring
smallpox disease during a campaign led by the World Health Organization. The basis of
cross-protection was demonstrated by Edward Jenner who deliberately inoculated an
eight year old boy first with freshly isolated cowpox virus (CPXV) from a lesion on a
dairy maid and subsequently with VARV (2). Jenner’s hypothesis that immunization with
CPXV would confer protection to smallpox challenge was confirmed when the child
displayed no signs of smallpox disease.
Despite eradication of natural smallpox infection, the possibility of deliberate
release of VARV during a potential bioterrorist event remains. Additionally, other
orthopoxviruses increasingly cause emerging zoonotic infection including monkeypox
virus, which is primarily localized to Africa but caused a recent outbreak in the
Midwestern United States (3-5). There have also been increasing reports of zoonotic
CPXV infection in Europe, where CPXV is endemic in the rodent population (6-10).
Despite reports of increasing zoonotic infections, vaccination is no longer routinely
recommended or practiced. While most immunocompetent individuals tolerate
vaccination with little to no problem, significant side effects have been reported in
patients who are immunocompromised and those with eczema and atopic dermatitis (9,
11). In addition, the protective immune response diminishes over time in vaccinated
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individuals (12-14). This has resulted in a population that is increasingly susceptible to
zoonotic orthopoxvirus infections.
The origin of VV is unknown, although there is some speculation that VV arose
following multiple passages of CPXV during the course of smallpox eradication (15).
Due to the widespread propagation of VV strains that were ultimately used to eradicate
smallpox, VV became the prototypical orthopoxvirus for study of immunomodulation
and host-pathogen interactions (16). Some studies have examined immune evasion by
VV with the goal of generating safer vaccines. These studies have resulted in the
development of attenuated vaccine strains including ACAM200 and modified vaccinia
Ankara (MVA), which were derived from serial in vitro passaging and targeted deletions
of immunomodulatory genes, respectively (17, 18). Since VV also elicits a strong cellular
and humoral immune response, other studies have examined its use as a vector to bolster
immunizations against other pathogens (18). These studies have demonstrated that VVvectored immunization increases the immune response to cancer antigens and several
pathogens including human immunodeficiency virus and rabies virus. Thus, many studies
have both examined immunomodulation of the host immune system and exploited the
immunostimulatory response by VV.
Increasing numbers of reports indicate that zoonotic CPXV infections are
predominantly caused by skin scratch inoculation following interaction with an infected
animal (6-9) whereas zoonotic infection with VV very rarely occurs, especially as the
host reservoir is unknown (19). CPXV has the largest genome in the Orthopoxvirus genus
and its host reservoir is the wild rodent population in Europe (10, 20-22). Since CPXV
and the mouse have co-evolved, this makes host-pathogen interplay relevant to study in a
mouse model. Another area of interest for research into CPXV biology is examination of
3

the large arsenal of potential host range and immunomodulatory open reading frames
(ORFs) encoded by CPXV. Analysis of CPXV unique ORFs may highlight particularly
important host immune responses for resistance to orthopoxviruses that cannot be studied
using other orthopoxvirus genus members. Therefore, continued study of primary
immune responses to orthopoxviruses in a matched host-pathogen relationship, such as
mouse-CPXV, is of interest to provide additional insight into the host immune response
which may lead to novel clinical advances to protect against emerging orthopoxvirus
infections.

Viral Immune Evasion
Orthopoxvirus genome size varies greatly, from 130kb to 290kb, and many ORFs
are highly conserved between genus members. The central coding region, encoding ORFs
responsible for viral replication and life cycle, is highly conserved among all
orthopoxvirus family members (22). The genetic termini are more variable among
orthopoxviruses, and are where ORFs involved in host range and immunomodulation are
located. Orthopoxviruses contain many virally encoded proteins that act in combination
to subvert both intracellular and extracellular host immune responses (23, 24).
Intracellular inhibition by orthopoxviruses occurs through numerous viral proteins
acting at different levels of respective anti-viral signaling pathways. Host recognition of
orthopoxvirus infection is mediated by pattern recognition receptors (PRRs) such as tolllike receptors, NOD-like receptors and intracellular RNA sensors, including retinoic acid
inducible receptors (RIG-I) and melanoma differentiation associated gene-5 (MDA5)
(24-27). Orthopoxviruses encode inhibitory proteins that sequester double stranded RNA
to evade recognition by RIG-I and MDA5. Also, numerous virally encoded proteins
4

interfere with signaling cascades downstream of PRRs to prevent host recognition. These
mechanisms of inhibition have been well characterized and virally encoded regulators
have been identified at most levels of signaling pathways (16, 23). In addition to
inhibiting signaling pathways downstream of host recognition by PRR, several inhibitory
proteins produced by orthopoxviruses have dual functions in inhibiting apoptotic
signaling pathways (28). Orthopoxviruses also encode intracellular inhibitory proteins
that prevent surface expression of major histocompatibility complex class I (MHC class
I) to escape detection by the cytotoxic CD8+ T cell response (29-32). Thus,
orthopoxviruses encode numerous intracellular immune evasion proteins that interfere
with multiple host responses.
Orthopoxvirus mediated control of the host response also occurs extracellularly
through a number of mechanisms. These include expression of virally encoded binding
proteins for cytokines, chemokines and complement proteins to inhibit the recruitment of
lymphocytes and thus progression of the inflammatory response. There are numerous
cytokines that orthopoxviruses target to prevent inflammation including type I interferons
(IFNs), IFN-!, tumor necrosis factor " (TNF-"), IL-1 and IL-18, with some
orthopoxviruses encoding more than one ORF to target each cytokine (23, 33-35).
Orthopoxviruses interfere with chemokine signaling and recruitment by encoding both
chemokine binding proteins and proteins that can bind to and saturate
glycosoaminoglycans on host surfaces where chemokines normally bind following
secretion (36-38). Modulation of the inflammatory immune response by orthopoxviruses
includes the induction of anti-inflammatory cytokines like IL-10 (39). Due to constant
selective pressure from co-evolution with their hosts, orthopoxviruses have developed a
number of strategies to subvert the host immune response.
5

Host Response to Orthopoxvirus Infection
Despite numerous immunomodulatory proteins encoded by orthopoxviruses, in
general, a strong humoral and cellular immune response is elicited following infection,
conferring lasting immunity including cross-species protection (14, 17, 40). Infection
with orthopoxviruses leads to the generation of neutralizing antibodies against both the
intracellular mature virion and the extracellular enveloped virus resulting in a longlasting antibody-mediated protection. Generation of neutralizing antibodies requires
CD4+ T cells and is first detectable 14 days following vaccination and persists for
decades. In the absence of B cells, but not CD4+ or CD8+ T cells, naïve hosts challenged
with orthopoxvirus succumb to infection indicating that an antibody response is essential
for survival. Although T cell responses are not required for survival, they prevent viral
replication and spread immediately following inoculation (17). In contrast to CD8+ T
cells, whose function peaks 2 to 4 weeks post vaccination before primary responses
decline, the CD4+ T cell response is long lived (14, 40). Prophylactic treatment of naïve
Rhesus macaques with human vaccinia immunoglobulin from vaccinated individuals is
protective, even in the absence of memory CD4+ or CD8+ T cell responses (14). On the
other hand, in the absence of B cells, CD4+ and CD8+ memory T cells can confer
protection to VV(40). These strong cellular and humoral responses confer both resistance
and long-lived cross-species protection against orthopoxvirus infection.
In addition to the requirement for a strong adaptive immune response, many
elements of the innate immune system have been implicated in resistance to
orthopoxvirus infection. These include induction of pro-inflammatory cytokines such as
IL-12 and IL-18 that mediate TH1 skewed adaptive immune priming and activation of
6

both NK cells and T cells (41, 42). Additionally, mice infected with VV that ectopically
expresses IL-15 survive infection through the activation of NK cells (43). Dendritic cells
(DCs) can sense infection through PRRs and secrete IL-12, IL-15 and IL-18 which
stimulate activation of NK cells (44, 45). Despite several in vitro studies demonstrating
inhibition of maturation and induction of apoptosis in DCs upon orthopoxvirus infection,
in vivo infection results in up-regulation of co-stimuatory molecules and production of
IL-12 (46-48). However, a requirement for DCs to mediate protection from orthopoxvirus
infection has not been demonstrated in vivo. Similarly to orthopoxvirus infection of DCs,
in vitro infection of macrophages results in apoptosis. However, in vivo macrophage
depletion in an intranasal model of infection results in increased susceptibility (49, 50).
These in vivo studies indicate that DCs and macrophages confer protection against
orthopoxvirus infection. Thus redundancy in host immune responses to orthopoxvirus
infection confers resistance and protection.

Natural Killer Cells
Natural killer (NK) cells are innate immune lymphocytes that play an important
role in the response to tumors and infections by inducing lysis of transformed or infected
cells and producing cytokines that help shape other immune responses. Activation of NK
cell function is mediated through two distinct mechanisms: integration of signaling
through inhibitory and activating receptors (51, 52) and cytokine stimulation (45, 53, 54).
Down-regulation of MHC class I, which normally mediates strong inhibitory signaling in
uninfected cells, renders cells sensitive to NK cell lysis (55). Ligands for activation
receptors can either be pathogen-derived or host-derived and up-regulated upon cell
stress (56, 57). While stimulation with cytokines, such as IL-12, IL-15 and IL-18, has
7

been shown to be effective at activating NK cells to produce other cytokines, NK cell
effector functions are largely determined locally since cell-cell contact is required for NK
cell-mediated lysis of infected cells. Ultimately, it is the integration of these signals that
determines NK cell functionality.
Following activation, NK cells function by lysing target cells or secreting
cytokines. Lysis of virally infected cells is mediated through granzyme B and perforin
(58, 59). Activation of NK cells through cytokine signaling or activation receptor
engagement results in cytokine production by NK cells including IFN-!, TNF-" and
granulocyte-macrophage stimulating colony factor (GMCSF) (60-62). Following
stimulation, NK cells produce pro-inflammatory chemokines, including CCL3, CCL4 and
CCL5, that recruit macrophages and other lymphocytes to the site of inflammation (63,
64). These coordinated actions of NK cells limit viral replication, induce inflammation
and prime an adaptive immune response at early times following infection.

Chemokines and Chemokine Receptors
The immune response is marked by recruitment of innate and adaptive
lymphocytes to the site of infection or inflammation and to secondary lymphoid organs.
Recruitment of lymphocytes is mediated through multiple mechanisms, but one of the
best characterized is chemokine-mediated trafficking. Chemokines have conserved
cysteine residues and from which their nomenclature is derived (65). Some of these
molecules are constitutively expressed, as is the case for CCL19 and CCL21 which
recruit T and B cells into secondary lymphoid organs through high endothelial venues
(66). During inflammation, there is induction of inflammatory chemokine expression that
is responsible for recruiting innate and adaptive lymphocytes to the site of infection or
8

inflammation (67, 68). There is some suggestion that chemokines act not only in
recruitment but also possess direct antimicrobial activity (69). Once chemokines are
secreted, they bind to surface expressed glycosaminoglycans. Promiscuous binding
occurs between inflammatory chemokines and their receptors, suggesting a need for
redundancy in this recruitment system.
Chemokine receptors are G protein-coupled receptors (GPCRs) that contain seven
transmembrane spanning regions (65, 70). As with other GPCRs, chemokine receptors
signal via guanine nucleotide-binding proteins (G proteins) which become active when
GDP is exchanged for GTP, activating downstream signaling cascades (70). It is well
known that pertussis toxin blocks GPCRs by ribosylating the GDP on the G protein,
locking it in an inactive state and preventing downstream signaling (71). Lymphocytes
express an array of chemokine receptors, allowing trafficking during development,
homeostatic conditions and to sites of inflammation.
The recruitment of NK cells in homeostatic and inflammatory conditions has been
well studied in human systems, but many discrepancies exist in the murine model (7274). Since infection with different pathogens stimulates and/or inhibits the production of
different chemokines, NK cells must require the expression of several chemokine
receptors for proper localization to control infection (75-79). However, many of these
studies do not address murine pathogens, so conclusions about murine NK cell
chemokine receptor requirements remain somewhat unclear.

A Protective Role for NK Cells Following Orthopoxvirus Infections
Our understanding of NK cells and their requirement for orthopoxvirus resistance
is in the context of VV and ectromelia virus (ECTV) infection, although the endemic
9

hosts for these viruses remains obscure. In systems where NK cells are lacking, such as in
genetic deficiency or following systemic antibody depletion, viral infection is
uncontrolled and results in lethality (80-82). During ECTV infections, the NK cell
receptors, CD94 and NKG2D, are required for protection and NK cells producing IFN-!
and granzyme B expand in the draining lymph node (81, 83). Additionally, the transfer of
Thy1+ memory NK cells is protective against lethal challenge with VV infection (84).
These data indicate that NK cells are an important component of innate immunitymediated resistance to ECTV and VV.
Since CPXV has co-evolved with its rodent hosts, CPXV infection of rodents is
appropriate for the study of orthopoxvirus-host interactions. However, the role of NK
cells in CPXV infection has not been investigated. CPXV has the largest genome in the
orthopoxvirus genus (20) and contains several ORFs not found in either VV or ECTV
genomes. This includes two ORFs, CPXV012 and CPXV203, that potently downregulate the expression of MHC class I (29-32).While this might render the infected cell
sensitive to NK cell-mediated lysis, CPXV also encodes another ORF, CPXV018, that
binds in vitro with high affinity to the NKG2D activation receptor and blocks its
recognition of ligands on target cells (85). Additionally, all orthopoxviruses encode a
number of cytokine binding proteins which could also limit the activation of NK cells,
such as one specifically targeting IL-18 (34), a well known mediator of NK cell
activation. NK cell activation could also be non-specifically subverted through virally
encoded chemokine binding proteins that may limit lymphocyte recruitment, including
NK cells, to the site of infection (38, 86, 87). Thus the role of NK cells following CPXV
infection was unclear.

10

In these studies, we developed a model of footpad inoculation using CPXV
infection and demonstrated that it mimics the natural route of viral transmission both
within the host population to zoonotic hosts. Using this model of inoculation, we
determined that NK cells were required in response to CPXV infection. Furthermore, we
investigated the mechanisms of NK cell recruitment to the draining LN following CPXV
infection including examination of chemokine-mediated trafficking and up-stream
signaling requirements. While NK cells were required for resistance to CPXV infection,
we also observed that CPXV was inhibiting their function and further examined this
inhibition by using CPXV deletion-mutant viruses in our footpad infection model. These
studies extend the requirement of NK cells to CPXV infection and additionally provide
novel insights into NK cell trafficking and stimulation following orthopoxvirus infection.
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CHAPTER 2:
Materials and Methods
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Mice
Mice were maintained according to institutional guidelines under specific pathogen free
conditions. C57BL/6Ncr (CD45.1) mice and B6.LY5.2/Cr (CD45.2) mice were obtained
from the National Cancer Institute (Fredrick, MD). CCR7-/-, CXCR3-/-, CCR2-/-, IFN!R-/and CD11c-DTR transgenic mice were obtained from Jackson Laboratory (Bar Harbor,
ME) and bred in our facility. CCR5-/- and C57BL/6 control mice were obtained from
Taconic (Germantown, NY). Batf3-/- mice were a kind gift from the laboratory of Dr.
Kenneth Murphy (Washington University, St Louis) and were also previously
described(88). All mice were used between 6 and 12 weeks of age.

Cells and Viruses
CV-1 and Vero cells were obtained from the American Tissue Culture Center (ATCC,
Manassas VA) and maintained in recommended media. BMDCs were generated by
culturing bone marrow cells with Flt-3 ligand (200ng/mL) for 9 days at 37°C at 5% CO2.
Cowpox virus strain Brighton Red and Vaccinia virus strain Western Reserve were
plaque purified three times from laboratory stocks initially obtained from the ATCC on
CV-1 tissue culture cells. Viral stocks were amplified in Vero cells and isolated following
cell lysis by centrifugation through 36% sucrose solution. Viral titers of these stocks were
assessed by standard plaque assays on confluent CV-1 monolayers.

Infection
Mice under anesthesia were infected in the right rear footpad with 1.5x106 pfu in 25µL
volume of virus diluted in PBS. At 1, 2, 3, 6 or 9 dpi, LNs, spleen, kidneys, lungs, liver,
feet, uterus and ovaries were isolated. Organs that were used to determine viral titers
13

were frozen at-80°C until processing and organs that were used to assess viral genome
copies were frozen at -20°C until DNA extraction.

Flow Cytometry
For samples analyzed by flow cytometry, LNs and spleens were crushed in R10 (RPMI,
10% FCS, L-glutamine and pen-strep). When macrophages and DCs were stained,
spleens and LNs were diced and incubated in liberase TL (Roche, Indianapolis, IN) for
45 minutes at 37°C in 5% CO2 prior to being crushed. Red blood cells in splenocytes
were lysed before staining for flow cytometry. For later experiments, prior to
extracellular staining the cells were stained with cell fixable viabilty dye (eBioscience,
San Diego, CA). Antibodies used for flow cytometry analysis were purchased from both
BD Biosciences and ebiosciences: NK1.1 (PK136), NKp46 (29A1.4), CD3 (145-2C11),
CD19 (1d3), CD11c (HL3), Ly6G (1A8), CD11b (M1/70), F4/80 (BM8), CD45.1 (Ly5.1,
clone A20), CD45.2 (Ly5.2, clone104), CD49b (DX5), Ly49CIFH (14B11), Ly49AD
(12A8), NKG2D (CX5), CD94 (18d3), CD62L (MEL-14), CD103 (2E7), CD-69
(H1.2F3), CD127 (A7R34), Siglec H (551), and Klrg1 (2F1). Surface staining of cells
was performed on ice in staining buffer (3% FBS, 0.1% NaN3 in PBS) with 2.4G2 (antiFc!RII/III) to prevent non-specific antibody binding. When staining for IFN-! and
granzyme B, whole LNs or red blood cell lysed splenocytes were first incubation in R10
containing Brefeldin A (GolgiPlug, BD) for 20-30 minutes at 37°C in 5% CO2 before
extracellular staining. After surface staining, cells were fixed and permeablized using a
Cytofix/Cytoperm kit (BD Pharmingen) or Mouse FoxP3 Buffer Set (BD Pharmingen)
according to manufacturer’s instructions. Antibodies used for intracellular staining were
IFN#! (XMG1.2), Ki67 (B56), FoxP3 (FJK-16s), and Granzyme B (clone GB-12,
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caltag). Flow cytometry data were collected on BD FACSCantoTM using FACSDiva
software (BD) and analyzed using FlowJo software (Tree Star, Ashland, OR).

Viral Titers
Traditional plaque assays were done using organ lysates generated by beat beading three
times in 1mL of RPMI. Serial dilutions were plated in duplicate on confluent CV-1
monolayers grown using minimal FCS. Cells were stained 2dpi using a crystal violet
solution and plaques were counted. Quantitative PCR was used as a more sensitive
measurement of viral genome copy numbers. DNA was generated from organs and was
then amplified using StepOnePlus (Applied Biosystems) in a 10µL volume containing 2x
Universal PCR Master Mix, No AmpErase UNG (Roche). Quantitative PCR DNA probes
are non-extendable oligonucleotides labeled with 5’ 6-FAM reporter and 3’ Zen / Iowa
Black FQ quencher dyes. Primer/probe sets were obtained from IDT DNA and sequences
are indicated in Table 1. Samples were run in duplicate, genome copy number was
normalized to $-actin copy number and numerical values obtained were multiplied by
1000.

Depletion
To systemically deplete NK cells, 200µg of NK1.1 antibody (PK136) or control antibody
(mAR) was injected IP 2 days prior to infection. For neutralization of IFN-!,
250µg/mouse of H22 antibody or control PIP antibody, a kind gift from the Dr. Robert
Schrieber laboratory (Washington University, St Louis), was injected 2 days prior to
infection. In the CD11c-DTR mice, of diphtheria toxin (Sigma) diluted in PBS was first
tested at 20, 10 and 5 ng/g body weight of the mouse to determine a dose that selectively
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depleted DCs but not NK cells or macrophages in the draining lymph node when injected
in the leg. For recruitment experiments, 5 ng/g body weight was administered in the hind
leg 1 day prior to infection. To deplete macrophages, 50µL of commercially available
liposomes that encapsulated clodronate or PBS were injected in the footpad in the foot 5
days prior to infection (Encapsula, Nashville, TN).

Chemokine RNA expression
Draining and non-draining LNs were isolated and RNA was extracted using Trizol
following the manufacturer’s instructions (Invitrogen, Carlsbad, California). cDNA was
then generated using 500ng of the isolated RNA using Superscript III Reverse
Transcriptase according to manufacturer’s protocol (Invitrogen). Quantitative PCR was
then performed as described for viral genome copies except values were only normalized
to $-actin and were otherwise unmanipulated. Primer/probe set sequences are indicated in
Table 1.

Adoptive Transfers
For adoptive transfer experiments, donor splenocytes were purified from C57BL/6
CD45.1, CCR7 (CD45.2) or CXCR3 (CD45.2) knockout mice and red-blood cells were
lysed. For the pertussis toxin or PBS pre-treatment, cells were plated at a density of
3x107/mL in R10 with either 100ng/mL pertussis toxin or PBS and incubated at 37°C in
5% CO2 for 2 hours before cells were then washed 4 times with PBS. All transferred cells
were labeled with 2.5µM CFSE (CellTrace, Invitrogen). The labeling reaction was
quenched using 10% FCS in RPMI. Cells were then washed twice in PBS, passed
through a 40µm cell strainer and resuspended in a volume such that animals could be
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injected IV with 200µL volume. BMDCs were injected either into the top of the foot of
the mouse in a volume of 20µL or intravenously injected in a volume of 100µL.

Multiplex Gene Expression Analysis
LNs from CPXV infected mice were isolated, homogenized in QuantiGene sample
processing buffer (Affymetrix, Santa Clara, CA) and then incubated at 65°C for 30
minutes before being stored at -80°C. Samples were further processed and run using a
custom multiplex set of beads (Affymetrix) for controls and all listed chemokines by the
Genome Technology Access Center (Washington University, St Louis, MO). Chemokine
expression was normalized first to Hprt1 transcripts and fold change was assessed by
normalizing to the appropriate non-draining LN control. Heat maps were generated using
Jcolorgrid (UCSF, San Francisco, CA (89)).

Cytokine Bead Array
Organs were homogenized in 1mL RPMI and supernatants were used in the mouse
inflammation kit (BD Bioscience) following the manufacturer’s protocol. Data were
collected using the BD FACSCaliburTM using CellQuest Pro Version 4.0 (Mac, BD
Biosciences) and BD CBA Version 1.4 (Mac).

Ex Vivo Lymphocyte Stimulation
Following infection, LNs were harvested and lymphocytes were isolated and incubated
for 1 hour with with 0.5 !g phorbol myristate acetate (PMA, Sigma-Aldrich) and 4 !g
ionomycin (Calbiochem) at 37°C in 5% CO2. After 1 hour of incubation, Brefeldin A
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(GolgiPlug, BD) was added and cells were incubated an additional 7 hours a 37°C in 5%
CO2 before staining as previously described.

Immunohistochemistry
LNs were harvested directly into PLP (0.05 M lysine phosphate buffer, pH 7.4, 0.05 %
glutaraldehyde, 0.002 mg NaIO4 ml21, 0.5 % paraformaldehyde) with 0.1% Triton X100 fixative for at least 8 hours then dehydrated in 30% sucrose overnight. Tissues were
then embedded in OCT in Tissue-Tek (Sakura Finetek) and snap frozen in 2methylbutane cooled over dry ice before being stored at -80C until use. Cryostat sections
were cut 9µm thick before being rehydrated in PBS and blocked with 10% goat serum in
2.4G2 for 30 minutes. Sections were incubated with primary stain for 2 hours at room
temperature, washed 3 times, and incubated in secondary stain for 1.5-2 hours. Primary
antibodies used were anti-CD3 (FITC) and unconjugated anti-CD169 (AbD Serotec) and
secondary antibody AlexaFluor594 (Molecular Probes). Sections were washed 3 more
times in PBS and mounted in VectaShield mounting medium with DAPI (Vector
Laboratories Inc, Burlingame, CA). Images were acquired using a Nikon Eclipse 80i
microscope and processed using MetaMorph (Molecular Devices, Sunnyvale, CA).
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Table 1: Quantitative PCR primer/probe sets.
Primer and probe sequences for RNA expression are shown in a 5’ to 3’ orientation.
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CPXV
5’-CGGCTAAGAGTTGCACATCCA-3’
!-actin
5’-AGCTCATTGTAGAAGGTGTGG-3’
Chemokine Receptors
CCL19
5'-CGCATCATCCGAAGACTGAAG-3'
CCL21
5'-GGGAACCTCTAAGTCTGGAAAG-3'
CXCL9
5'-CAAATCCCTCAAAGACCTCAAAC-3'
CXCL10 5'-TCATCCCTGCGAGCCTAT-3'

Forward

Table 1: Primer and Probe Sequences

5'-CCAAGAACAAAGGCAACAGCACCA-3'
5'-AAGGAAAGGGCTCCAAGGGCT-3'
5'-CCCCAAGCCCCAATTGCAACAA-3'
5'-CCCACGTGTTGAGATCATTGCCAC-3'

5-TTTACTCAAGACACAGGGCTC-3'
5'-TTGAGGGCTGTGTCTGTTC-3'
5'-GATCTCCGTTCTTCAGTGTAGC-3'
5'-CTTGATGGTCTTAGATTCCGGAT-3'

Probe
5’-AGGACGTAGAATGATCTTGTA-3’
5’-TTCAGGGTCAGGATACCTCTCTTGCT-3’

Reverse
5’-TCTGCTCCATTTAGTACCGATTCTAG-3’
5’-GGTGGGAATGGGTCAGAAG-3’

CHAPTER 3:
Host Response to Cowpox Virus Footpad Infection
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In vivo studies of CPXV are relatively rare and have typically utilized intranasal
inoculation (30, 39, 90). These infections model the natural route of smallpox virus
transmission and the proposed mechanism of dissemination by bioterrorists. However,
the natural route of transmission for CPXV is contact-mediated both within the host
reservoir during zoonotic spread to other species including humans (6, 8, 91). We have
therefore examined CPXV infection using a footpad injection model in order to study the
immediate host response to infection under normal physiological conditions. Only a few
studies have employed CPXV footpad infection and there are no data available
documenting the host response regarding this route of infection (92, 93). Therefore, we
first sought to characterize the immediate immune response in the down-stream popliteal
LN.

Determining Infectious Dose
In order to choose a dose to study a sublethal inoculation and infection that occurs
following zoonotic transmission, we performed survival studies in C57BL/6 mice using
an intraperitoneal (IP) route of inoculation which mimics systemic infection. We chose to
perform survival studies with this route of infection because a previously published
reports indicate that footpad infection with CPXV does not result in lethality (92, 93).
C57BL/6 mice were inoculated with doses of CPXV ranging from 1.567x106 pfu/mouse
to 1.26x108 pfu/mouse and mortality and morbidity were observed. This survival curve
experiment indicated an LD50 of 1.155x107 pfu/mouse during systemic infection. When
mice were challenged IP with CPXV, all mice showed signs of illness including ruffled
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fur and hunched posture. Additionally some, but not all mice developed lesions on their
tails which resolved by 30 days post infection (dpi). Mice treated with higher doses of
CPXV also lost of up to 10% of original weight before either succumbing to infection or
recovering (Figure 1A). Following initial weight loss, surviving mice gained weight and,
by 28 dpi, ranged from 100-125% of initial weight. At the lowest dose studied, 1.567x106
pfu/mouse, all of the mice survived infection. Therefore, all subsequent experiments were
carried out using a dose of 1.5x106 pfu/mouse. By choosing this sublethal systemic dose
of virus, we were then able to perform our studies in hosts with ensured survival.

Lymphocyte Expansion Following CPXV Infection
The LN plays a crucial role in immunosurveillance by collecting infectious
antigens from the periphery in an environment that increases the likelihood of interaction
between antigen presenting cells (APCs) and circulating naïve and memory T and B cells
(94). One of the hallmarks of infections and inflammatory reactions is lymphadenopathy.
This is the consequence of recruitment, expansion and retention of lymphocytes in the
draining LN while an immune response is primed resulting in characteristically swollen
LNs. Indeed, following footpad infection with CPXV, the draining popliteal LN was
enlarged and many lymphocyte populations were expanded.
Innate lymphocytes including macrophages, neutrophils, and DCs, play a critical
role in limiting viral replication and spread early following infection as well as
simultaneously priming an appropriate adaptive immune response. These innate
lymphocytes are characterized by their ability to phagocytose viral particles and
recognize infection via PRRs which then stimulates an antiviral state (95, 96). Both
macrophages and neutrophils function by producing inflammatory cytokines,
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antimicrobial products, and reactive nitrogen and oxygen species that directly kill
infected cells. Following CPXV infection, we have found that while macrophages were
more quickly expanded, both macrophage and neutrophil populations were substantially
increased by 3 dpi (Figure 2A, 2B). Pathogens are also phagocytosed and detected in the
draining LN by resident DCs or at the site of infection, stimulating trafficking of
migratory DCs to the draining LN (97, 98). The detection of most infections that occur in
the periphery is mediated by a variety of migratory DC subsets, including dermal and
Langerhan DCs. These migratory DCs are then thought to be responsible for stimulating
the immune response in the draining LN either directly or indirectly by passing antigens
to LN resident DCs. Surprisingly, the migratory DC population did not greatly expand at
early time points following CPXV footpad infection in comparison to the homeostatic
trafficking of this subset found in the non-draining LN (Figure 2C). In contrast, the LN
resident DC population was significantly increased at 2 and 3 dpi, suggesting that this
subset of DCs might play a more significant role following CPXV infection (Figure 2D).
Whether LN resident DCs were expanded via in situ proliferation or recruitment and
differentiation of blood monocytes was not determined at this time. All of these data
demonstrated that innate immune cell populations are expanded in the draining LN
following CPXV footpad infection.
The LN is an important site for priming an adaptive immune response as it
provides a location for relatively rare naïve and memory T and B cells to interact with
antigen bearing APCs. Under homeostatic conditions, T and B cells are recruited to the
lymph node from circulation through high endothelial venules (99). If these cells do not
encounter APCs displaying cognate antigens, they then either migrate out through the
efferent lymph or are returned to circulation through the thoracic duct (94). When a T or
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B cell recognizes its cognate antigen displayed on an APC, they are arrested in the LN
where they undergo clonal expansion and acquire effector functions including cytolytic
ability, antibody production and directional homing to the site of infection. Following
CPXV infection, we found an increase in the total numbers of both T and B cells in the
draining LN suggesting that there was an increased recruitment or retention of these cells
to select CPXV-specific T and B cells (Figure 3A, 3B). When a marker of the cell cycle
was examined in the T and B cell populations, we found that the majority of these cells
were not replicating (Figure 3C, 3D). Therefore, as expected, T and B cells are recruited
to and retained in the draining LN following CPXV infection.
Under homeostatic conditions in the mouse, NK cells are excluded from LNs as
they do not express CCR7, which binds to CCL19 and CCL21 produced by cells in high
endothelial venules (74). Following CPXV infection, we observed a statistically
significant increase in the percent and total number of NK cells in the draining lymph
node following infection beginning as early as 18 hours post infection (hpi) (Figure 4A,
4B). This expansion occurred quite rapidly and was maintained for up to 6 dpi before the
NK cell population began to contract. These data indicated that the NK cell population is
specifically expanded in the draining LN, suggesting a potential role following CPXV
infection. Aside from the migratory DC population, all lymphocyte populations examined
expanded following CPXV footpad inoculation in the C57BL/6 system.

CPXV Replication and Spread
Zoonotic CPXV disease in immunocompetent humans is often limited to the site
of infection, with little to no spread of lesions from the site of inoculation (9). In order to
determine if and where CPXV was able to spread and replicate following footpad
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inoculation in mice, we measured viral titers in a variety of organs. First, traditional
plaque assays were performed to assess viral titers in the draining LN, spleen, and liver.
We found that CPXV was capable of infecting and replicating in the draining LN (Figure
5A) but that there was limited spread to the spleen where there appeared to be little to no
replication of the virus, indicated by consistently low titers over time (Figure 5B). In
contrast, in the liver no plaques were observed at any time, suggesting CPXV did not
spread to this organ following footpad infection (data not shown). These data
demonstrated that CPXV can spread from the site of inoculation and replicate to high
titers in the draining lymph node.
Since qPCR provides a more sensitive measurement of viral replication, we used
this method to further characterize viral spread by quantitating viral genome copy number
in the draining LN, lungs, spleen, liver, kidney, uterus and ovaries. Viral genome copies
again demonstrated that CPXV could infect and replicate in both the draining LN and to a
high degree (Figure 6B). Meanwhile, minimal copy numbers were found in the lung and
spleen (Figure 6C, 6D) while very few to no genome copies were found in the liver,
kidney, uterus and ovaries at 3 dpi (Figure 6E, 6F, and 6G), but viral genome copies were
elevated in all organs except the spleen at 6 dpi. The data obtained by qPCR from the LN
and spleen showed a similar trend to the data obtained by traditional plaque assay,
validating this technique. We were also able to detect some viral replication in the liver at
6 dpi, in contrast to traditional plaque assay, demonstrating the increased sensitivity of
this system.

NK Cells Prevent Viral Replication
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NK cells have been shown to be important for resistance to systemic infection
with VV and footpad infection with ECTV (80-82). As the NK cell population was
highly expanded in the draining lymph node following infection, we hypothesized that
they were playing a role limiting CPXV infection. To investigate this hypothesis, we
performed systemic antibody mediated depletion of NK cells prior to infection with
CPXV (100). We found that following NK cell depletion (Figure 6A), viral replication in
the draining LN was significantly increased in comparison to control antibody treated
mice (Figure 6B). Additionally, there was a subtle trend toward increased viral spread in
the spleen and more significantly in the lung when NK cells were not present at both 3
and 6 dpi (Figure 6C, 6D). The depletion of NK cells did not lead to an increased
complete systemic spread at early times following infection, as viral replication in the
liver, kidney, uterus and ovaries (Figure 6E, 6F and 6G) did not increase at 3 dpi. Lack of
NK cells also did not affect secondary viremia in these organs at 6 dpi, suggesting NK
independent that CPXV spread is. In addition to increased viral replication in the draining
LN at 3 and 6 dpi, there was also a subtle delay in the clearance of CPXV from the LN
and foot in NK cell depleted mice in comparison to control antibody treated mice at 12
dpi (Figure 7, 7B). Taken together, these data suggest that the expanded NK cell
population is playing a role in limiting viral replication which prevents systemic viral
spread.

Discussion:
Here we demonstrate that lymphocyte expansion in the draining LN in response to
CPXV footpad infection does not appear to be impaired despite the expression of
numerous virally encoded inhibitory proteins. Almost all populations of lymphocytes
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examined were expanded in the draining LN except for migratory DCs. Additionally, we
found a substantial increase in the NK cell population whose role in CPXV infection has
not been previously studied. CPXV replication appears to be limited to the LN at early
time points following infection, but can later spread to other organs. Following systemic
depletion of NK cells, we found dramatic increases of viral burden in the draining LN.
Also, spread to some but not all organs was affected in mice lacking NK cells, implying
that NK cells prevent dissemination to distant sites.
Many in vivo studies of orthopoxvirus family members focus on routes of
infection that model either systemic or aerosolized infections (30, 39, 90). Few studies
exist that model a natural route of infection that mimics natural transmission both within
the host reservoir and to zoonotic hosts. Rare studies have employ a footpad model of
infection using CPXV, and these do not address the host response (10, 92, 93). Moreover,
zoonotic infections have only been studied after development of symptoms leaving the
immediate innate immune response to CPXV undocumented.
Zoonotic infections in immunocompetent humans are characterized by lesions
that are limited to the site of inoculation, where it is thought that CPXV infects through
abrasions in the skin. These lesions resolve in approximately two weeks. Other symptoms
also include fever, myalgia, headache, nausea and lymphadenopathy (6, 8, 9). In the
footpad model, mice also develop lymphadenopathy, do not develop lesions outside the
region of inoculation and become disease free after 2-3 weeks. It appears that the footpad
model in mice closely mimics the zoonotic infection of humans making it a relevant
model system to study CPXV.
A previous study using CPXV footpad inoculation was performed in outbred mice
and reported replication limited to the footpad and a lack viral spread and replication
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(93). Further viral or host responses were not examined. We used the C57BL/6 strain of
mice in these studies because many genetic knockouts have been developed this
background including many host response factors which may play a role in the response
to CPXV infection. In contrast to the previous study, when we examined titers in
C57BL/6 after footpad inoculation, we found extensive replication in the draining LN
and evidence of spread to the spleen by plaque assay. This discrepancy between this and
previous studies is most likely due to the differences between strains of mice and the
infectious dose. We were also able to detect viral genome copies not only in the LN and
spleen but also in the lungs, kidney, liver, uterus and ovaries using a sensitive
quantitative PCR method.
We next assessed the contribution of the innate immune response to
lymphadenopathy by monitoring various lymphocyte populations in the draining LN over
the course of infection. A detailed examination of lymphocyte populations following
CPXV infection has, to our knowledge, not previously been undertaken.
Lymphadenopathy resulted from an expansion of most lymphocyte populations
examined, including both innate and adaptive lymphocyte populations. Lymphocyte
populations appeared to expand normally following CPXV, with the potential exclusion
of migratory DCs. An expansion of this population was never observed following CPXV
infection in levels greater than the homeostatic migration in the non-draining LN.
Whether the lack of migratory DC expansion is due to apoptosis at the site of infection
following primary infection of the DCs or due to a specific inhibition of migratory DC
recruitment to the draining LN is unknown. Following examination of the expansion of
lymphocytes in the draining LN, we were most interested in the robust expansion of the
relatively rare LN NK cell population. NK cells are known to be important not only for
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lysis of infected cells, but also for priming a TH1 adaptive immune response when
recruited to draining LNs. We thus postulated that NK cells might be important for
resistance to CPXV infection. In addition, a role for NK cells has also, to our knowledge,
never been studied following CPXV infection but has been demonstrated to be important
for resistance to other orthopoxviruses such as VV and ECTV.
CPXV has the largest genome in the orthopoxvirus genus (20) and contains
several open reading frames not found in either VV or ECTV genomes. This includes two
ORFs, CPXV012 and CPXV203, that potently down-regulate the expression of MHC
class I (29-32).While this might render infected cells sensitive to NK cell-mediated lysis,
CPXV also encodes another ORF, CPXV018, that binds in vitro with high affinity to the
NKG2D activation receptor, blocks its recognition of ligands on target cells and prevents
in vitro NKG2D mediated lysis (85). Additionally, all orthopoxviruses encode a number
of cytokine binding proteins which may also limit the activation of NK cells, such as one
specifically targeting IL-18 (34), a well known mediator of NK cell activation. It is
therefore possible that NK cell populations may be expanded but effectively blocked
from functioning by the immunomodulatory ORFs expressed by CPXV. In addition to
these known potential modulators for NK cell function, additional unknown modulators
may exist.
To investigate whether NK cells were playing a role in CPXV resistance, we
performed systemic depletion of NK cells prior to footpad infection. The most striking
increase in viral burden after depletion occurred in the draining LN, where we measured
a two-log increase in viral replication. We also observed a more subtle increase in viral
genome copy number in the lung and spleen at both 3 and 6 dpi, suggesting that NK cells
prevent spread to these organs at these time points. Another subtle increase in viral
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burden at later time points following infection was observed in the draining LN and in the
foot, indicating that NK cells also play a role in viral clearance. Whether this was due to
limiting initial viral burden shortly after infection or due to priming of the adaptive
immune response is still unknown. This pattern of increased viral burden suggested to us
that NK cells were playing an important role in the draining LN where viral replication
was limited thus preventing viral spread.
It is important to note that when C57BL/6 mice were inoculated in the footpad, no
mice succumbed to infection. This is in contrast to the increased mortality of mice
following systemic depletion or genetic absence of NK cells during infection with either
ECTV or VV (80-82). It is possible that NK cell depleted mice would succumb to
infection following a larger dose of CPXV, but increased mortality was observed even
with sub-lethal doses of ECTV and VV. Thus, while NK cells play an important role in
resistance to CPXV, similar to ECTV and VV, they are not absolutely required for
survival.
Also, despite viral dissemination at later time points after CPXV footpad
infection, no lesions have been observed outside the site of inoculation. These data
suggest that the primary site of early CPXV infection and replication is the foot and
draining LN, from where it may rarely escape into the blood and be spread to the spleen
and/or lungs. If CPXV replicates to sufficient titers in the draining LN and footpad, a
secondary viremia may occur in other organs at later time points. In addition, this route of
infection seems to mimic zoonotic infection where there is primary replication at the site
of inoculation and systemic disease is not observed. This makes the footpad route of
infection a relevant model to study both spread within the host reservoir, but also
zoonotic spread in humans.
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Figure 1: Morbidity and mortality following CPXV footpad infection.
Age and sex matched C57BL/6 mice were inoculated in the footpad with indicated doses
of CPXV in 25µL volume. Mice were weighed every day for the first 11 days, then every
other day for the next week and before sacrifice at the conclusion of the experiment. (A)
Weight change and (B) mortality over time following CPXV infection are depicted.
N=10 mice for 1.26x108 pfu/mouse and 6.3x107 pfu/mouse, n=8 mice for 1.4x107
pfu/mouse, n=7 mice for 4.7x106 pfu/mouse and n=6 mice for 1.567x106 pfu/mouse.
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Figure 2: Kinetics of innate lymphocyte expansion following CPXV footpad
infection.
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs
were isolated, stained and analyzed by flow cytometry. Following exclusion of dead
cells, total (A) macrophages (F4/80+CD11b+), (B) neutrophils (Ly6G+SSC+), (C)
migratory DCs (CD11c+MHCIIhigh) and (D) LN resident DCs (CD11c+MHCII+) were
identified. Cell numbers were ascertained using trypan blue exclusion, then multiplied by
the percentage of population found by FACS analysis. A graph depicting the average of
3 independent experiments is shown.
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Figure 3: Kinetics of adaptive lymphocyte expansion following CPXV footpad
infection.
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs
were isolated, stained and analyzed by flow cytometry. Total (A) T cells (CD3+CD19NK1.1-) and (B) B cells (CD19+CD3-NK1.1-) were identified. Cell numbers were
ascertained using trypan blue exclusion, then multiplied by the percentage of population
found by FACS analysis. A graph depicting the average of 5 independent experiments is
shown. Following extracellular staining, lymphocytes were fixed, permeablized and
stained for Ki67. Total (C) T cells (CD3+CD19-NK1.1-Ki67+) and (D) B cells
(CD19+CD3-NK1.1- Ki67+) were identified. A graph depicting the average of 3
independent experiments is shown.
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Figure 4: Kinetics of NK cell expansion following CPXV footpad infection.
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106
pfu/mouse and at indicated times, lymphocytes from the non-draining and draining LNs
were isolated, stained and analyzed by flow cytometry. (A) Percent and (B) total NK cells
(NK1.1+CD3-CD19-) were identified. Cell numbers were ascertained using trypan blue
exclusion, then multiplied by the percentage of population found by FACS analysis. The
graphs depict average of n=6 independent experiments (18 hpi), n=14 independent
experiments (1 dpi), n=3 independent experiments (36hpi), n=8 independent experiments
(2 & 3 dpi), and n=2 independent experiments (6 & 9dpi). Paired Student’s t-test: (*) = p
< 0.05; (**) = p < 0.005; (***) = p < 0.0005.
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Figure 5: CPXV titers following footpad inoculation.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu of CPXV in the
footpad and at indicated times, organs were removed and viral titers were assessed in the
draining LN (A) and spleen (B) by plaque assay. Dotted lines indicate the limit of
detection by the assay. Symbols indicate individual mice and the mean and SEM are
depicted. N=4 to 5 mice/group were analyzed for each time point.
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Figure 6: Systemic NK cell depletion leads to increased viral burden in some but not
all organs following early footpad inoculation.
Age and sex matched C57BL/6 mice were treated IP with 200µg control (mAR) or NK
cell-depleting (anti-NK1.1, PK136) antibody 2 days prior to infection and 4 dpi. (A) NK
cell depletion was assessed in the non-draining LN by staining lymphocytes and
identifying NK cells (NK1.1+NKp46+CD3-CD19-) cells. Cell numbers were ascertained
using trypan blue exclusion, then multiplied by the percentage of population found by
FACS analysis. At indicated time points, organs were removed and viral titers were
assessed by quantitative PCR in the (B) LN, (C) lungs, (D) spleens, (E) livers, (F)
kidneys and (G) uterus and ovaries. CPXV copy number was normalized to $-actin copy
numbers and then multiplying by 1000. Symbols indicate individual mice and lines
indicate the mean. N=4 to 5 mice/group were analyzed for each time point. Data are
representative of 2-3 independent experiments.
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Figure 7: CPXV persists longer in mice that were systemically depleted of NK cells.
Age and sex matched C57BL/6 mice were injected IP with 200µg/mouse of control
(mAR) or NK cell depleting (anti-NK1.1, PK136) antibody 2 days prior to infection, 4
and 10 dpi. At indicated time points, (A) LNs and (B) feet were isolated. DNA was
generated and CPXV copy number was normalized to $-actin copy numbers and then
multiplied by 1000. Symbols indicate individual mice and lines indicate the mean. N=4 to
5 mice/group were analyzed for each time point.
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CHAPTER 4:
The Mechanism of NK Cell Recruitment
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Following CPXV footpad infection we saw a dramatic and rapid expansion of NK cells in
the draining LN. Murine NK cells are known to lack expression of CCR7, the
homeostatic chemokine receptor responsible for T and B cell trafficking into secondary
lymphoid organs in response to its ligands CCL19 and CCL21 (74). It is this lack of
CCR7 expression that is thought to lead to the exclusion of murine NK cells from the LN.
Therefore, it was of interest to determine the mechanism of NK cell population expansion
following CPXV infection.

The Expansion of the NK Cell Population is Not Due to Proliferation
The rapid expansion of the NK cell population in the draining LN following
CPXV could be the result of either in situ proliferation or the recruitment of NK cells
from other areas. To determine if NK cells were undergoing proliferation, we isolated
NK cells from the draining LN and co-stained them for Ki67, a cell cycle marker. While
some NK cells isolated from the draining LN did stain positively for Ki67, the majority
of NK cells did not express Ki67 (Figure 8). These data indicate that NK cell population
expansion is mediated by active recruitment of NK cells to the draining LN following
CPXV infection.

NK Cell Subset Surface Staining Profiles
There are several subsets of NK cells residing in different organs that have been
characterized (101-103). Research has predominantly been performed with NK cells
isolated from the spleen as it contains a large population of NK cells that is easy to
isolate. Several groups, including our lab, have also characterized a rare alternatively
matured subset of thymic NK cells. To determine if the expanded NK cell population
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resulting from CPXV infection resembled either of these subsets, we analyzed NK cells
isolated from the draining LN, non-draining LN, spleen and thymus for markers that can
differentiate these populations.
Splenic NK cells have high expression of Mac-1 (CD11b), Ly49 family receptors,
L-selectin (CD62L), DX5 (CD49b), CD94, and NKG2D (CX5) (102). NK cells isolated
from the draining lymph node expressed identical surface levels of splenic markers as
NK cells isolated from the spleen (Figure 9A-F). In contrast, NK cells isolated from the
thymus expressed lower levels of splenic markers. Thymic NK cells have been shown to
highly express the IL-7 receptor " (IL7R", CD127) and "E integrin (CD103) (102).
When NK cells from the draining LN were examined, they did not express thymic
surface markers (Figure 10A, 10B). Again, NK cells isolated from the spleen and the
draining LN had identical expression profiles for these thymic surface markers.
Additionally, when we examined the expression of splenic and thymic markers on NK
cells isolated from the non-draining LN, we found intermediate expression of Mac-1, Lselectin and IL-7R". Taken together, these data show that NK cells expressing splenic
markers are recruited to the draining LN.

NK Cell Expansion is Pertussis Toxin Sensitive
Given the rapid kinetics of the NK cell population increase, the minimal number
of replicating NK cells, and the splenic surface marker profile of the NK cells isolated
from the draining LN, we hypothesized that NK cells were being recruited to the draining
LN. We isolated splenocytes from congenic mice and pre-treated them in vitro for 2
hours with either PBS or pertussis toxin. Following pre-treatment, the cells were washed
extensively, labeled with CFSE and mixed together before adoptive transfer into
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congenic C57BL/6 mice. We found that donor splenic NK cells treated with PBS
specifically increased in the draining LN following adoptive transfer and CPXV infection
(Figure 11A, 11B). The increase in the transferred PBS-treated NK cells was similar to
the kinetics of host NK cell increase following CPXV infection, supporting the
hypothesis that splenic NK cells are being recruited to the draining LN following CPXV
infection.
These findings led us to consider chemokine receptor-dependent NK cell
recruitment into the draining LN. As with other GPCRs, chemokine receptors signal via
G proteins and these signals are blocked by pertussis toxin (70, 71). We thus used
pertussis toxin to test whether chemokine receptors were important for the NK cell
increase in the draining LN. Pertussis toxin pre-treated splenic NK cells were never found
in the draining LN at any time point following CPXV infection (Figure 11B). Although it
is difficult to fully control for off-target effects of petussis toxin treatment, these data
further substantiate the possibility that splenic NK cells are being recruited to the
draining LN following CPXV infection and additionally suggest that NK cell recruitment
occurs via chemokine receptors.

CPXV Infection Specifically Up-regulates Inflammatory Chemokines in the
Draining LN
As the data suggested a role for chemokines and chemokine receptor-mediated
recruitment of NK cells following CPXV infection, we next determined specifically
which of these were required. To examine chemokine expression in the draining LN, we
assessed transcript levels over time following CPXV infection by use of a comprehensive
bead-based array. In both draining and non-draining LNs over time, we examined 33
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transcripts simultaneously: Ccl1, Ccl2, Ccl3, Ccl4, Ccl5, Ccl6, Ccl7, Ccl8, Ccl9, Ccl11,
Ccl12, Ccl17, Ccl19, Ccl20, Ccl21, Ccl22, Ccl24, Ccl25, Ccl27, Ccl28, Cxcl1, Cxcl2,
Cxcl3, Cxcl5, Cxcl9, Cxcl10, Cxcl11, Cxcl12, Cxcl13, Cxcl14, Cxcl15, Cxcl16 and Xcl1.
Our analysis of these data was then informed by gene expression microarray data
from a previously published study (59) and confirmed by our laboratory, indicating that
NK cells express transcripts for Ccr2, Ccr5, Cx3cr1, Cxcr3, Cxcr4 and Cxcr6. We found
that transcripts of ligands for CCR2 and CCR5, including Ccl2, 3, and 7, were upregulated approximately 3- to 9-fold relative to the non-draining LN transcripts (Figure
12). Additionally, the ligands for CXCR3, namely IFN-! inducible transcripts Cxcl9, 10
and 11, were up-regulated from 5 to 19-fold relative to transcript levels in the nondraining LN. While transcripts for Cxcl11 were the most highly induced, CXCL11
protein is not expressed in C57BL/6 mice due to a point mutation (104). Finally, we did
not find an increase in ligands for CXCR4 and CXCR6 (CXCL12 and CXCL16,
respectively). Nonetheless, CPXV infection induces up-regulation of chemokine ligands
for chemokine receptors expressed on NK cells.

CXCR3 but not CCR2 or CCR5 Is Required for Full NK Cell Recruitment
Our analysis of chemokine up-regulation following CPXV infection and NK cell
expression of specific chemokine receptors suggested selective involvement of CCR2,
CCR5 or CXCR3 in the recruitment of NK cells. To further analyze these possibilities,
we examined NK cell recruitment in chemokine receptor-deficient mice. Despite upregulation of transcripts for Ccl2, Ccl3 and Ccl7, there were little to no defects in
recruitment of NK cells in mice lacking either CCR2 or CCR5 (Figure 13A, 13B). Thus,
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CCR2 and CCR5 individually do not contribute to NK cell recruitment following CPXV
footpad infection.
We next studied NK cell trafficking to the draining LN in CXCR3-deficient mice.
In these mice, we found that there was a substantial defect at 3 dpi, resulting in a marked
decrease in trafficking of NK cells following CPXV infection, although NK cell
recruitment at earlier times was relatively unaffected (Figure 13C). In order to determine
whether these CXCR3-dependent trafficking defects were NK cell intrinsic or extrinsic,
we adoptively transferred a mixture of enriched splenic NK cells from wild-type and
CXCR3-deficient mice into congenic C57BL/6 mice (Figure 13D). We found that the
fold change of recruited donor-derived NK cells for the adoptively transferred CXCR3deficient NK cells was lower than for the adoptively transferred wild-type NK cells,
especially at later time points as observed directly in the CXCR3-deficient mice (Figure
14C). These results indicate that NK cells intrinsically require CXCR3 expression for
maximal recruitment.

Discussion
Two mechanisms could explain NK cell expansion in the draining LN following
CPXV infection: either in situ proliferation of rare murine LN NK cells or recruitment
from the blood and other organs. A specific cell cycle marker indicated that while some
NK cells in the draining LN were proliferating, the majority of the expanding NK cell
population were not. In support of these data, NK cells in the draining LN expressed
splenic markers and recruitment of transferred splenic NK cells was pertussis toxin
sensitive. Comprehensive analysis of chemokine receptor expression on NK cells in
combination with chemokine expression following infection in the draining LN focused
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our studies on CCR2, CCR5 and CXCR3. Although transcripts for ligands of these
receptors were up-regulated, only CXCR3 was required on the NK cell for full
recruitment following CPXV infection.
Productive interactions between NK cells and their targets require recruitment of
NK cells to the relevant site. In non-infectious settings, several studies have implicated
the requirement for CXCR3-mediated NK cell trafficking including following corneal
epithelial injury (105), implantation of tumor cells that endogenously express IFN-!
(106), and LPS-matured dendritic cell footpad injection (107). In contrast, during
parasitic and viral infections, NK cells have differential requirements for chemokine
receptors, generally not including CXCR3. Following intratracheal inoculation of
neutropenic mice with Aspergillus fumigatus, CCR2 is required (75) whereas CCR5 is
required in Toxoplasma gondii (76) or Herpes Simplex Virus 2 (HSV2) (108) infections,
with higher pathogen burden in CCR5-deficient mice. However, Aspergillus and HSV2
are not natural pathogens of rodents. For protection against MCMV, a natural pathogen
of mice, recruitment of NK cells to the liver is mediated through CCR2 (68, 77). CXCR3
and CCR5 are also important for NK cell trafficking from the red pulp to the T cell zone
in the spleen following injection of polyI:C and MCMV infection (109). Finally, CXCR6
is required for memory NK cells in the liver that respond to contact-mediated
hypersensitivity or virus-like particles (79). Thus, several chemokine receptors are
involved in recruitment of NK cells though little is known about NK cell recruitment to
the draining LN in the context of natural rodent pathogens.
In contrast to other studies using other pathogens and NK cell recruitment to other
organs (68, 75-77, 108), we found no role for CCR2 or CCR5 individually in recruitment
of NK cells to the draining LN following CPXV inoculation. However, it is still possible
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that they function redundantly in the individually deficient mice as CCR2 and CCR5
share several of the same ligands (70). To formally determine if CCR2 and CCR5 are
required, a mouse lacking both CCR2 and CCR5 must be generated and tested. This
would likely require the production of a single targeting construct containing deletions of
both CCR2 and CCR5 since their genes are located within about 15 kb of each other
(genome.ucsc.edu), making it unlikely that a double knockout can be readily generated
by mating the CCR2- and CCR5-deficient mice. Additionally, since we analyzed
chemokine transcript levels, not protein levels, is possible that actual chemokine proteins
were not up-regulated following infection. Further complicating interpretation
experiments in chemokine receptor deficient mice, CPXV encodes numerous chemokine
binding proteins which may interfere with CCR2 or CCR5 function.
On the other hand, we found that CXCR3 was intrinsically required for full
recruitment following CPXV infection. Expression of CXCR3 on NK cells has been
shown to be important for the recruitment of NK cells to tumor sites (106) and to the
draining LN following deliberate LPS-matured dendritic cell footpad injection (107).
CXCR3 also plays a role in re-localization of NK cells from the red pulp to the T cell
zone of the spleen during MCMV infection (109), another rodent specific virus.
Therefore our data is in agreement with previously published data demonstrating the
importance of CXCR3 in the recruitment of NK cells in the context of infection with
natural rodent pathogens. These data suggest that CXCR3 mediates NK cell trafficking
under both non-infectious and infectious inflammatory conditions.
Defective NK cell recruitment in CXCR3-deficient mice is most evident at 3 dpi
when the largest increase in NK cells normally occurs. Earlier time points are less
affected, suggesting that there is at least one other mechanism for NK cell recruitment
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that is independent of CXCR3. There are several hypotheses that might explain this
CXCR3-independent NK cell recruitment. One possibility is that CX3CL1, the ligand for
CX3CR1, plays a role in NK cell recruitment. However, expression of CX3CL1 was not
examined in the transcriptional chemokine expression array so the need for this receptor
remains unknown. If expression of CX3CL1 was found in the draining LN relative to the
non-draining LN, mice deficient for CX3CR1 are available and NK cell recruitment
could easily be studied in them. Another possible mediator of recruitment may be upregulation of another chemokine receptor on NK cells during active infection. We did not
evaluate this possibility because of the low numbers of NK cells in the draining LN and
the procedural concerns regarding FACS sorting of CPXV-infected samples. Taken
together, these data suggest that in addition to CXCR3, at least one other chemokine and
chemokine receptor pair may function to recruit NK cells to the draining LN.
Alternately, it is also possible that NK cells are being recruited in a nonchemokine receptor dependent manner. Other chemotactic compounds that are induced
by inflammation also cause NK cells to traffic including lysophosphatidic acid (LPA),
complement component C5a, N-formyl-methionyl-leucyl-phenylalanine and leukotrienes
(74). LPA is involved in a variety of signaling pathways and interacts with GPCRs,
conferring pertussis toxin sensitivity, but its role following any pathogenic infection has
not been shown (110). In contrast, poxviruses are known to encode a number of
complement control proteins that have been extensively studied using ECTV or VV but
not CPXV (23, 24, 111). Meanwhile, the importance of leukotrienes for NK cell
recruitment could be quite complicated. Orthopoxviruses, including CPXV, have an
obligate requirement for arachidonic acid metabolites for replication both in vitro and in
vivo (112, 113). However, arachodonic acid can be used as a precursor for pro54

inflammatory signaling molecules, including leukotrienes. To control the inflammatory
response, CPXV encodes p38, which inhibits the synthesis of a specific intermediate that
can be used in pro-inflammatory mediator synthesis. It is therefore possible that these
alternate mediators of recruitment could also play a role in NK cell recruitment following
CPXV infection.
NK cells also express sphingosine-1-phosophate 5, another GPCR, which senses a
high concentration of sphingosine-1-phosphate in the blood. In mice deficient in S1P5, it
has been demonstrated that there is a decrease in the number of NK cells in the blood,
lungs and spleen and increase in the LN and bone marrow, suggesting that it plays a role
in NK cell egress (114). Following infection, it is possible that S1P5 becomes depressed
in the blood to allow for lymphocyte retention, including NK cells, in secondary
lymphoid organs to prime an immune response. Thus it is possible that CXCR3independent NK cell recruitment does not require another chemokine receptor, but does
require another GPCR or pro-inflammatory mediator.
Here we demonstrate that NK cell expansion was not due to active replication of
rare LN NK cells but was due to recruitment of splenic NK cells. This recruitment was
chemokine receptor-dependent and we identified the NK cell intrinsic requirement for
CXCR3. Deficiency of CXCR3 alone, however, does not abrogate the recruitment
phenotype, suggesting requirement of additional chemokine receptors or other
inflammatory mediators.
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Figure 8: Expansion of the NK cell population cannot fully be explained by in situ
proliferation.
Age and sex matched C57BL/6 mice were infected as before and at indicated time points,
cells from the draining and non-draining LN were isolated and stained. Following
extracellular staining, cells were fixed, permeablized and intracellularly stained for Ki67.
Total Ki67 expressing NK cells were identified by gating on NK cells (NK1.1+CD3CD19-) then looking for those that expressed Ki67. Cell numbers were ascertained using
trypan blue exclusion, then multiplied by the percentage of population found by FACS
analysis. The graph depicts the average of 3 independent experiments.
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Figure 9: NK cells isolated from the draining LN following CPXV infection
phenocopy surface staining of splenically derived NK cells.
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained.
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) Mac-1
(CD11b), (B) pan-Ly49 family receptors (Ly49ADCIFH), (C) L-selectin (CD62L), (D)
DX5 (CX5), (E) CD94 and (F) NKG2D was determined. A representative result of 2
independent experiments is shown. Surface staining remained the same when observing
NK cells isolated from these organs at 2 and 3 dpi.
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Figure 10: Draining LN NK cells do not express markers of thymic NK cells.
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained.
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) IL-7R"
(CD127) and (B) integrin "E (CD103) was determined. Representative results of 2
independent experiments are shown. Surface staining remained the same when observing
NK cells isolated from these organs at 2 and 3 dpi.
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Figure 11: NK expansion in the draining LN is pertussis toxin sensitive following
CPXV infection.
Splenocytes isolated from congenic C57BL/6 (CD45.2) and B6.LY5.2 (CD45.1) mice
were pre-treated in vivo with PBS or pertussis toxin for 2 hours at 37°C, 5% CO2 before
being washed, CFSE labeled, mixed and co-injected IV into C57BL/6 mice. Immediately
following adoptive transfer, the mice were infected with 1.5x106 pfu of CPXV in the
footpad. At the indicated time points, LNs were harvested and NK cells (NK1.1+CD3CD19-) were identified. Host NK cell recruitment (CFSE-) (A) or donor NK cell
recruitment (CFSE+) (B) is shown over time. Data are representative of 2 independent
experiments.
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Figure 12: Inflammatory chemokine transcripts are up-regulated following CPXV
infection.
RNA transcript levels were assessed in age and sex matched C57BL/6 mice infected with
1.5x106 pfu of CPXV in the footpad at indicated time points by multiplex gene
expression analysis. LNs from 3 independently infected mice were isolated and lysates
from either the non-draining or draining LN were generated, run in triplicate, and
chemokine transcripts normalized to the control Hprt1 transcript for each sample. The
fold change indicated in each square depicts the average transcript level in the draining
LN relative to the non-draining LN.
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Figure 13: NK cell recruitment occurs in the absence of CCR2 and CCR5 but
intrinsically requires CXCR3 expression following CPXV infection.
Age and sex matched C57BL/6 and (A) CCR2-deficient, (B) CCR5-deficient or (C)
CXCR3-deficient mice were infected with 1.5x106 pfu of CPXV. At indicated time
points, lymphocytes from the non-draining and draining LNs were isolated, stained and
analyzed by flow cytometry. Total NK cells (NK1.1+CD3-CD19-) were identified. The
graphs are the average of 3 independent experiments. (D) B5.LY5.2 (CD45.1) and
CXCR3-/- (CD45.2) splenocytes were isolated and enriched by negative selection before
being CFSE labeled, mixed and co-transferred IV into C57BL/6 mice. One day after
transfer, mice were infected as before and NK cell populations were examined at
indicated time points. To analyze the recruitment in this system, the total number of
recruited wild-type or chemokine deficient NK cells at 2 and 3 dpi were compared
relative to the initial time point at 1 dpi. A representative result of 3 independent
experiments is shown.
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CHAPTER 5:
Up-stream Requirements for NK Cell Recruitment and Viral Burden
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NK cell recruitment to the draining LN is mediated through chemokine induction
in the draining LN and at least one chemokine receptor on the NK cell. The induction of
inflammatory chemokines indicated that there is viral recognition in the draining LN.
This chapter explores the upstream requirements for NK cell recruitment, including the
cells required and the signaling pathway leading to inflammatory chemokine induction.

IFN-! is Required for NK Cell Recruitment
As discussed previously, ligands for CXCR3, including CXCL9 and CXCL10, are
induced by IFN-!. In order to further investigate the role that IFN-! was playing upstream
of NK cell recruitment, we examined mice that were deficient for IFN-! receptor 1
(IFN!R1). These mice still produce IFN-! but are unable to respond to its stimulus.
Following CPXV infection, we observed a lack of recruitment of NK cells at both 2 and 3
dpi (Figure 14A). In fact, at these time points, levels of NK cell recruitment were lower
in IFN!R1-deficient mice than in CXCR3-deficient mice, suggesting that other factors
important for NK cell recruitment are also induced by IFN-!.
Another method we employed to demonstrate the importance of IFN-! was to
observe NK cell recruitment in C57BL/6 mice given an injection of control or IFN-!
neutralizing antibody two days prior to infection. The lack of NK cell recruitment at 3 dpi
in mice treated with neutralizing antibody recapitulated the results seen in IFN!R1deficient mice (Figure 14B). In mice that received control antibody, the NK cell
recruitment observed was similar to NK cell recruitment in CPXV infected
unmanipulated mice. Interestingly, there did not appear to be a defect at 2 dpi. This could
be explained by incomplete inhibition of IFN- ! signaling by neutralizing antibody or
insufficient localization to the draining LN until later time points.
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Supporting our hypothesis that IFN-! is upstream of CXCR3 signaling required
for NK cell recruitment, Cxcl9 and Cxcl10 transcripts were not induced in mice that were
pre-treated with IFN-! neutralizing antibody (Figure 14C, 14D). Meanwhile, CPXV
infection in control antibody treated mice induced high levels of Cxcl9 and Cxcl10
transcripts at 3 dpi. The inhibition of Cxcl9 and Cxcl10 transcript induction was selective,
as expression of control transcripts for homeostatic trafficking chemokines Ccl19 and
Ccl21 showed little to no difference between control and IFN-! neutralizing antibody
treatment (Figure 14E, 14F). Taken together, these data indicated that IFN-! is crucial for
the selective induction of chemokines responsible for NK cell recruitment following
CPXV infection.

CCR7 is Extrinsically Required for NK Cell Recruitment
Murine NK cells do not express transcripts or protein for CCR7, which leads to
their exclusion from secondary lymphoid organs in mice (74). When analyzing the
microarray data, we also confirmed a lack of Ccr7 transcript expression in both resting
and cytokine activated NK cells. Expression data published online also demonstrate low
levels of Ccr7 in NK cells relative to other lymphocytes such as T cells (immgen.com).
During our analysis of the individual chemokine receptor deficient mice, as a control we
also examined mice deficient for CCR7. Surprisingly, given the absence of expression of
Ccr7 transcripts in NK cells, mice lacking CCR7 had a complete reduction of NK cell
recruitment at all time points observed following CPXV infection (Figure 15A).
The classical paradigm of pathogen sensing for peripheral DCs involves upregulation CCR7 expression during the maturation process (115, 116). This up-regulation
stimulates migration of DCs from the periphery to the draining LN where they directly
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prime the immune response or pass antigens to other LN resident cells that prime the
immune response (107). It is also well documented that after localization to the draining
LN, DCs interact with NK cells inducing a positive feedback loop, where DCs produce
IL-12, stimulating NK cells to produce IFN-! and subsequently causing further
maturation of the DCs and IL-12 production (44, 45, 53, 117).
It seemed a likely hypothesis that CCR7 was required for DC trafficking from the
foot to the LN, where they stimulated the recruitment of NK cells as a consequence of
this positive feedback loop. To verify the NK cell intrinsic or extrinsic requirement of
CCR7, we isolated and enriched NK cells from wild-type or CCR7-deficient congenic
mice, labeled the cells with CFSE and co-transferred them into congenic wild-type mice
prior to CPXV infection. We found that the transferred NK cells deficient in CCR7
trafficked with similar kinetics to co-transferred wild-type NK cells (Figure 15B). These
data indicated that the requirement for CCR7 was NK cell extrinsic as hypothesized.

Abolished Trafficking of NK Cells in Diphtheria Toxin Treated CD11c-DTR Mice
To test the potential requirement for DCs to induce recruitment of NK cells
following CPXV infection, we employed CD11c-DTR transgenic mice. These transgenic
mice encode the high affinity human diphtheria toxin receptor under control of the
CD11c promoter (118, 119). This system allows for selective depletion of cells
expressing CD11c when treated with diphtheria toxin. Given dosage variations found in
the literature and NK cell expression of CD11c, we first performed a dose-response
experiment with diphtheria toxin to determine the ideal concentration. Previously
published studies that used models of peripheral depletion administered as much as
20ng/g body weight of diphtheria toxin, but when we tested that dose, we found that NK
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cells and macrophage total cell numbers were also reduced (Figure 16A-D). Using a
lower dose of 5 ng/g body weight of diphtheria toxin, there appeared to be little reduction
of these cell types, but conventional DCs (CD11c+MHCII+) were still depleted (Figure
16E, 16F).
C57BL/6 or CD11c-DTR transgenic mice were treated with diphtheria toxin prior
to inoculation with CPXV. Following verification that the CD11c expressing DCs were
ablated in the diphtheria toxin treated transgenic mice but not in C57BL/6 mice, we next
examined the NK cell population. NK cell recruitment was not affected in control mice
treated with diphtheria toxin. In contrast, in the treated transgenic mice, we found that,
similar to the CCR7-deficient mice, recruitment of NK cells did not occur in response to
CPXV infection at either time point observed (Figure 16G). Taken together, these data
suggested that a CD11c- and CCR7-expressing cell, potentially a migratory DC, was
important for mediating NK cell recruitment following CPXV infection.

DCs Are Not Sufficient to Restore NK Cell Trafficking
Since depletion experiments indicated that DCs were involved upstream of NK
cell recruitment following CPXV infection, we next addressed if DCs were sufficient to
recruit NK cells. For these studies, we employed in vitro Flt3-matured BMDCs, which
have a less mature and inflammatory phenotype (97, 120). We also wanted to spatially
separate the injection sites of transferred BMDCs and virus since in vitro experiments
have shown that infection of BMDCs prevents up-regulation of maturation markers and
results in non-productive infection (47, 48, 121). Using the CCR7-deficient mice, we
injected BMDCs on the top of foot opposite from where we normally inject the virus.
Following transfer of BMDCs, we observed trafficking of transferred cells to the draining
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LN as has been previously reported (Figure 17A) (116). However, when BMDCs were
injected in the same foot as the virus, trafficking of BMDCs to the draining LN was
highly diminished. It is possible that the amount of virus injected is so overwhelming that
even a physical barrier does not prevent infection of the majority of the injected BMDCs
leading to either a lack of maturation and subsequent up-regulation of CCR7 required for
migration or apoptosis.
Additionally, in these experiments we began to encounter abnormalities in the
CCR7-deficient mice, such as inconsistent and expanded NK cell populations in the
draining LN following CPXV infection (Figure 17B). Further investigation of the
literature revealed that CCR7-deficient mice develop several types of spontaneous
autoimmune diseases, often resulting in lymphadenopathy (122, 123). Indeed,
examination of CCR7-deficient mice in our colony showed that there was a broad range
in the total number of cells in the draining LN, from 60,000 to 1,000,000 cells in
unmanipulated mice regardless of the age of the mouse (Figure 17C). In comparison,
total cells isolated from wild type mice were tightly grouped and fell around 500,000
cells per LN. This wide variation in total cell number in unmanipulated CCR7-deficient
mice makes it impossible to study NK cell recruitment in these mice.
Next, we attempted to complement NK cell recruitment in CD11c-DTR
transgenic mice that had been depleted of DCs prior to transfer of in vitro Flt3L-matured
BMDCs and inoculation with CPXV. When examining lymphocytes isolated from the
draining and non-draining LN, it was hard to detect transferred BMDCs in the CD11cDTR mice because LNs were markedly smaller (Figure 18A, 18B). Additionally, even
with very minimal numbers of BMDCs in the draining LN of mice deficient for DCs, NK
cells were not observed to be recruited to the draining LN following BMDC
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complementation (Figure 18C). Again, in control C57BL/6 mice, following footpad
injection of only BMDCs, there was trafficking of the transferred cells from the foot to
the draining LN which was diminished when CPXV was concurrently injected. These
results suggested that while DCs may be involved in NK cell recruitment following
CPXV infection, the minimal number that trafficked to the draining LN was not sufficient
for recruitment of NK cells and that another cell might also be required.

Dermal DCs Do Not Appear to Play a Role in NK Cell Recruitment
In vitro infection of BMDCs with orthopoxviruses prevents maturation of
BMDCs, demonstrated by the lack of up-regulation of MHC class II and co-stimulatory
molecules (47, 48, 121). As previously discussed, CPXV is known to express two ORFs
that potently down regulate expression of MHC class I on infected cells (29-32).
However, our lab has also demonstrated that CD8+ T cells are required for resistance to
CPXV infection, as systemic depletion of CD8+ T cells leads to decreased survival
following infection with a mutant CPXV that cannot down-regulate MHC class I (30). If
directly infected DCs cannot prime a CD8+ T cell response, then it is likely that the CD8+
T cell response is primed through cross presentation by a dermal DC subset that
expresses CD103 (97, 124, 125). Additionally, previous investigations examining
migratory DC trafficking from the periphery to the draining LN demonstrated that dermal
DCs arrived earlier than langerin-expressing DCs in the draining LN (126-128). This
earlier recruitment makes them likely candidate DC subset to stimulate early NK cell
recruitment. Given the importance of cross-presenting DCs for viral resistance, we
hypothesized that this dermal CD103 expressing DC subset was also responsible for NK
cell recruitment.
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We examined the role for cross presenting DCs by using BATF3-deficient mice,
which have been shown to selectively lack the CD103+ DC population (88). When we
infected the BATF3-deficient mice with CPXV, we found that there was little to no
difference in NK cell recruitment between the wild-type and BATF3-deficient mice at
time points observed (Figure 19A, 19B). These results suggested that cross-presenting
DCs were not essential for NK cell recruitment. Since we also did not observe increased
migratory DC recruitment to the draining LN and were unable to complement NK cell
recruitment with in vitro matured DCs, we hypothesized that another cell type was
important for stimulating NK cell recruitment in response to CPXV infection. However,
we remain unable to fully discount a possible contribution by a DC subset for NK cell
recruitment following CPXV infection.

Macrophage Depletion Leads to Deficiency in NK Cell Recruitment
Macrophages have been shown to line the SCS of the LN, where they
phagocytose and detect free viral particles that arrive from the periphery through the
lymphatics (94, 129, 130). Additionally, previous data from our lab using an IP
inoculation of CPXV that expresses GFP in the place of CPXV203 has demonstrate a
preferential infection of CD169+ macrophages in the draining mediastinal LN (78). In
agreement with these findings, several other labs have recently shown CD169+
macrophage co-localization with a number of pathogenic infections, including MVA and
VV, in the draining LN following cutaneous inoculation (131, 132). Finally, it has also
previously been demonstrated that the SCS macrophage population is sensitive to
diphtheria toxin depletion in the CD11c-DTR transgenic mice (133). In light of DCs
being necessary but not sufficient for the trafficking of NK cells to the draining LN
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following infection, we decided to examine the role that macrophages play in NK cell
recruitment.
To specifically deplete macrophages in the draining LN, five days prior to CPXV
infection we subcutaneously injected liposomes encapsulating clodronate. When
examined by immunohistochemistry and, as previously described, in mice were that
treated with clodronate-loaded liposomes the SCS macrophage population that express
CD169 was depleted in the LN (Figure 20A). Mice that received liposomes encapsulating
PBS had an intact macrophage population and recruited NK cells when examined by flow
cytometry 3 dpi (Figure 20B, 20C). In contrast, mice that were injected with clodronateloaded liposomes had minimal numbers of classical macrophages when examined by
flow cytometry and were not able to recruit NK cells. In fact, following macrophage
depletion and subsequent CPXV infection, many of the lymphocyte populations we had
previously examined showed decreased total cell numbers (Figure 20D-H). These data
indicated that macrophages are responsible not only for the recruitment of NK cells but
also other lymphocyte populations.

Macrophages and Chemokines Function Separately to Recruit NK Cells
Since macrophages produce many inflammatory cytokines and chemokines,
including CXCL9 and CXCL10 (134, 135), it seemed likely that they were responsible
for the CXCR3-mediated NK cell recruitment. Surprisingly, however, when we examined
chemokine expression in the draining LNs of mice treated either with control liposomes
containing PBS or liposomes containing clodronate, we found no decrease in transcripts
for Cxcl9 or Cxcl10 (Figure 21A, 21B). As a control for liposome injection, we observed
little to no difference in transcripts for Ccl19 and Ccl21 in the non-draining and draining
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LNs (Figure 21C, 21D). These data suggest that NK cells are being recruited through two
independent mechanisms and that chemokine-mediated recruitment may be necessary but
not sufficient for NK cell recruitment following CPXV infection.

Control of Viral Replication in Depleted Systems
To assess the impact of decreased numbers of NK cells in the draining LN on
control of CPXV infection, we again took advantage of CXCR3-deficient mice, where
NK cell recruitment following CPXV infection is diminished but not eliminated. We also
measured viral replication in CXCR3-deficient mice treated with control or NK cell
depleting antibody (Figure 22A). When control antibody was administered to both wildtype and CXCR3-deficient mice, viral replication in the draining LNs was similar (Figure
22B). When these mice were systemically depleted of NK cells, the viral replication was
increased in the draining LNs of both of these mice to similar extents. When examining
viral replication in the lung and spleen, we did not see any significant difference between
wild-type and CXCR3-deficient mice with or without NK cell neutralizing antibody
(Figure 22C, 22D). These data suggest that even the decreased NK cell population such
as that in CXCR3-deficient mice was sufficient to control local replication and prevent
systemic dissemination.
Following clodronate-loaded liposome treatment and subsequent infection there
were even fewer NK cells present in the draining LN than in the CXCR3-deficient mice.
We also speculated that because macrophages are preferentially infected following
cutaneous VV infection in the draining LN, that depletion of macrophages could lead to
removal of the primary site of viral replication (132). To examine the impact of lack of
these populations on viral control, we assessed whether there was a local decrease in viral
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burden in the draining LN and increase in systemic spread following macrophage
depletion. Even in the absence of macrophages and with minimal numbers of NK cells,
viral burden in the draining LN was equivalent in mice pre-treated with either PBS- or
clodronate-loaded liposomes (Figure 23A). These data indicated that replication of
CPXV in the draining LN was unimpaired in the absence of macrophages suggesting an
ability for CPXV to infect and replicate in another LN resident cell. Additionally, in
contrast to our hypothesis that a lack of macrophages would result in systemic
dissemination, there was no significant increase in viral burden in the lungs or spleens of
macrophage depleted mice (Figure 23B, 23C). It seems then that removing the
preferential target cell of CPXV did not impact viral replication or spread. Additionally,
even the minimal number of NK cells present in the draining LN following macrophage
depletion and CPXV infection was sufficient to control viral replication and spread.

Discussion
There are multiple factors required for NK cell recruitment to the draining lymph
node following CPXV infection. Innate lymphocyte detection of infection results in
cytokine induction, and we have dramatically demonstrated a lack of NK cell recruitment
in IFN!R1-deficient mice. Mice that have selectively been depleted of DCs or
macrophages demonstrate decreased NK cell recruitment indicating their importance for
this process. Although it appears that NK recruitment requires both IFN-! induced
chemokine expression, including CXCL9 and CXCL10, and SCS macrophages, these
pathways are not immediately linked. Finally, despite decreased NK cell recruitment,
viral replication was still controlled by the minimal numbers of NK cells still founding in
the draining LN following CPXV infection.
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It is well known that there are multiple interactions between DCs and NK cells
including DC mediated differentiation, maturation and activation of NK cells (44, 45, 53,
117, 136, 137). Recent studies also attempt to extend these interactions to include the
requirement of DCs for NK cell recruitment. During MCMV infection, when NK cells
trafficked into the white pulp of the spleen, they were preferentially associated with
ERTR7 expressing cells that were also associated with DCs (109). A more direct study
demonstrated that footpad injection of in vitro LPS matured DCs was sufficient to recruit
NK cells to the draining LN (107). Therefore, as these studies indicate a role for DCs in
NK cell recruitment, they appear to further contribute to the complex and established
dynamic crosstalk between these two subsets.
To our surprise, evidence in support the importance of DCs upstream of NK cell
recruitment appeared to be lacking following CPXV infection. Combining the results of
the CD11c-DTR transgenic system and BMDC complementation, DCs appeared to be
necessary but not sufficient for NK cell recruitment. However, these results remain
confounded by the absence of a good model system of DC deficiency that could be
complemented with an external source of DCs. While NK cells were not recruited in
CCR7-deficient mice, the cell populations and architecture of the lymph node are highly
distorted in these mice, leading to poor ability to prime a cellular immune response (99).
Additionally, given the random induction of autoimmunity in these deficient mice and
resultant lymphadenopathy, data collected in this system cannot be fully interpreted (99,
122, 123). There are also caveats when examining the diphtheria toxin treated CD11cDTR transgenic mice. There is ectopic expression of CD11c expression on non-DC
lymphocyte populations, leading to their ablation following diphtheria toxin treatment
along with conventional DCs (133). Furthermore, depletion of DCs in this system is not
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complete as only 85%-90% of DCs are depleted (138). Additionally, even at low doses of
diphtheria toxin, mice became ill and died within 6 days of injection as has been reported
in the literature (138). Attempts to restore NK cell recruitment by complementing DC
deficiency in these mice, even when examining early time points, were ultimately
unsuccessful in our hands. Given these off target effects of diphtheria toxin in CD11cDTR mice, data collected in this background can be difficult to interpret.
With these results in mind, we re-examined previously collected data for further
evidence that DCs might be involved in NK cell recruitment. We found that there was
little to no increase in migratory DC populations in the draining LN of C56BL/6 CPXV
infected mice. Additionally, we did not observe NK cell recruitment defects when
examining BATF3-deficient mice, indicating the cross-presenting DC population was
also not involved in recruitment. The only DC population in which we observed
expansion in the draining LN following CPXV infection was the LN resident DC
population. This population is seeded by the migration of monocytes into lymphoid
organs and their differentiation into DCs (115). However, it remains unknown if there is a
monocyte influx and differentiation into DCs in the draining LN following CPXV
infection.
The role of macrophages in NK cell recruitment is a relatively new idea, which
was published while we confirming our results. In several studies, macrophages were
shown to be important for NK cell recruitment to the CD169+ SCS macrophage area in
response to both bacterial and viral pathogens (131, 139, 140). When liposomes
encapsulating clodronate are injected in the footpad, NK cells no longer localize to the
SCS region and are not activated in response to MVA (140). In agreement with these
data, ablation of the CD169+ macrophage population followed by CPXV footpad
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infection resulted in decreased NK cell recruitment to the draining LN. These data
suggest that macrophages are involved in important upstream events which lead to NK
cell recruitment, including the detection of infection and direction of adaptive immune
response priming.
A recently published report found that macrophages are important for inducing
innate effector cell production of IFN-!. These cells included “innate” CD8+ T cells,
NKT cells and !% T cells. When the CD169+ macrophages were depleted, the protective
ability of these innate effector cells is reduced in response to Pseudomonas aeruginosa
(131). The IFN-! produced by these innate responders is important for controlling
bacterial load in the draining LN and preventing spread to the blood. However, when we
examined viral burden in mice that had been pre-treated with clodronate-loaded
liposomes prior to CPXV infection, we did not see a substantial increase in draining LN
titers, nor in titers at more distal sites in which we had previously seen spread following
systemic NK cell depletion. These data indicate that there are differential responses to
bacterial and viral infections by both NK cells and other innate immune lymphocytes.
There are several potential explanations as to why an increase in viral burden was
not observed following macrophage depletion. It is possible that the minimal number of
NK cells and the innate effector response were sufficient to suppress viral replication to a
similar extent as in unmanipulated mice. In contrast to systemic NK cell depletion, where
we did see an increase in viral burden both locally and distantly, NK cells in the draining
LN were significantly reduced in comparison to macrophage depleted and infected mice.
We have also observed this trend of viral control with minimal numbers of NK cells in
CXCR3-deficient mice. Only after NK cell depletion in the CXCR3-deficient mice was
there increased viral burden in the draining LN. While the CXCR3 draining LN did
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contain a larger population of NK cells than the clodronate-loaded liposome treated LNs,
it is possible that even the very small numbers of NK cells present in these conditions are
sufficient for viral control. Alternately, as it appears that orthopoxviruses preferentially
infect macrophages (132), it is possible that following macrophage depletion, viral
particles traffic through the lymph to the next LN (the inguinal or thoractic LNs) instead
of the blood. Future work to interrogate the mechanism of macrophage mediated NK cell
recruitment could examine viral burden in these LNs. Given similar viral burdens in the
draining LN after control- and clodronate-loaded liposome treatment, it appeared that
another cell is infected in the absence of macrophages. Perhaps this alternately infected
cell type does not raise a strong innate anti-viral immune response resulting in a
diminished inflammatory response and lymphocyte recruitment.
Recognition of CPXV infection and induction of an inflammatory response
including NK cell recruitment appears to be multifactorial and complex. Given the
inability of BMDCs to restore NK cell recruitment and the depletion of SCS
macrophages in diphtheria toxin treated CD11c-DTR transgenic mice, it appears that DCs
are insufficient to induce NK cell recruitment following CPXV infection. While depletion
of macrophages resulted in a decrease in the number of NK cells recruited, it did not
result in a decrease of IFN-! induced chemokine expression or increased local or
systemic viral burden. These data suggest a two step model for NK cell recruitment,
where chemokines are induced following infection and SCS macrophages provide an
unknown second signal.
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Figure 14: IFN-! is required for NK cell recruitment and inflammatory chemokine
expression.
(A) Age and sex matched IFN!R1-deficient and C57BL/6 mice were inoculated in the
footpad with 1.5x106 pfu/mouse and at indicated time points, lymphocytes from the nondraining and draining LNs were isolated, stained and analyzed by flow cytometry. Total
NK cells (NK1.1+CD3-CD19-) were identified. A representative result of 2 independent
experiments is shown. (B-E) Age and sex matched C57BL/6 mice were treated 2 days
prior to infection with 250µg of control (PIP) or IFN-! neutralizing (H22) antibody. (B)
Total NK cells (NK1.1+CD3-CD19-) were identified. The graph depicts the average of 3
independent experiments. (C-F) Transcript analysis of Cxcl9, Cxcl10, Ccl19 and Ccl21
was analyzed by quantitative PCR. The graph represents the average of data from 2
mice/group from 3 independent experiments. Unpaired Student’s t-test: (*) = p < 0.05;
(**) = p < 0.005; (***) = p < 0.0005; (****) = p < 0.0001.
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Figure 15: CCR7 is extrinsically required for NK cell recruitment to the draining
LN following CPXV infection.
(A) Age and sex matched CCR7-deficient and C57BL/6 mice were infected with CPXV
and NK cell recruitment was monitored as before. The graph depicts the average of 3
independent experiments. (B) C57BL/6 (CD45.1) and CCR7-/- (CD45.2) splenocytes
were isolated and enriched by negative selection before being CFSE labeled, mixed and
co-transferred intravenously into C57BL/6 mice. One day after transfer, mice were
infected as before and NK cell (NK1.1+CD3-CD19-) populations were examined at
indicated time points. To analyze the recruitment in this system, the total number of
recruited wild-type or chemokine knockout NK cells at 2 and 3 dpi were compared
relative to the initial time point at 1 dpi. A representative result of 3 independent
experiments is shown.
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Figure 16: NK cell recruitment is defective in CPXV infected CD11c-DTR
transgenic mice.
(A) Age and sex matched CD11c-DTR+/- and C57BL/6 mice were treated with 20, 10 and
5 ng/g body weight of diphtheria toxin. Lymphoid (A, C, E) and splenic (B, D, F) total
NK cells (A, B), total macrophages (C, D) and total conventional DCs (E, F) were
analyzed by flow cytometry. (G) For NK cell recruitment, a dose of 5 ng/g body weight
was chosen and administered 1 day prior to infection with CPXV. At 1 and 2 dpi, LNs
were harvested, treated with Liberase TL, and lymphocytes were isolated, stained and
analyzed by flow cytometry. The graph depicts the average of 3 independent
experiments.
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Figure 17: Inconsistencies in CCR7-deficient mice.
(A) Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the top of
the foot of CCR7-deficient mice. LNs were isolated 1 day later and treated with Liberase
TL following which lymphocytes were isolated, stained and analyzed by flow cytometry.
(B) Age and sex matched CCR7-deficient and C57BL/6 mice were infected and NK cell
recruitment was monitored as before. The graph depicts the average of 2 independent
experiments. (C) Total cells from the popliteal LNs from 3-4 unmanipulated CCR7deficient mice per age group and 1 unmanipulated C57BL/6 mouse were counted using
trypan blue exclusion. CCR7-deficient mice were examined at 2, 3 and 4 months of age
and from C57BL/6 mice at 2 months of age. Each symbol represents 1 popliteal LN from
a mouse, with both popliteal LNs represented on the graph.
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Figure 18: BMDCs do not complement NK cell recruitment defects seen in CD11cDTR transgenic mice following CPXV infection.
C57BL/6 and CD11c-DTR transgenic mice were age and sex matched and treated with 5
ng/g body weight of diphtheria toxin 1 day prior to injection of BMDCs and CPXV
infection. Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the
top of the foot while CPXV was injected in the bottom of the footpad of diphtheria toxin
treated CD11c-DTR mice and C57Bl/6 mice. LNs were isolated 1 day later and treated
with Liberase TL following which lymphocytes were isolated, stained and analyzed by
flow cytometry. (A) Percent and (B) total donor derived BMDCs
(CD11c+MHCIIhighCFSE+) and (C) total NK cells (NK1.1+CD3-CD19-) were assessed
and graphed. The graph represents 1 mouse for BMDC injected alone and CXPV injected
alone while BMDC and CPXV injected in the same foot represent the average 2 mice for
both CD11c-DTR and C57BL/6 mice.
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Figure 19: BATF3 deficiency does not affect NK cell trafficking following CPXV
infection.
Age and sex matched BATF3-deficient mice on a 129S6/SVEV background and
129S6/SVEV control mice were infected as previously described. Draining and nondraining LNs were isolated at 2 and 3 dpi and lymphocytes were isolated, stained and
assessed by flow cytometry for (A) percent and (B) total NK cells (NK1.1+CD3-CD19-)
as before. The graph depicts the average of 2 independent mice.
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Figure 20: Macrophage depletion leads to decreased lymphocyte recruitment.
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL
of either PBS- or clodronate-loaded liposomes. (A) A representative section of a
macrophage depleted draining LNs isolated 3 hpi following CPXV infection is shown
following staining with CD169+ (PE), CD3+ (FITC) and DAPI. The (B) total macrophage
population (F4/80+CD11b+), (C) total NK cell population (NK1.1+CD3-CD19-), (D) total
neutrophil population (Ly6G+SSC+), (E) total migratory DC population
(CD11c+MHCIIhigh), (F) total LN resident DC population (CD11c+MHCII+), (G) total T
cell population (CD3+CD19-NK1.1-) and (H) total B cell population (CD19+CD3-NK1.1-)
were observed by flow cytometry 3 dpi. The graph depicts the average of 2 mice from 2
independent experiments. Figure 1A was contributed by Dorothy Sojka.
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Figure 21: Inflammatory chemokine transcripts are unaffected by macrophage
depletion.
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL
of either PBS- or clodronate-loaded liposomes. Transcript analysis of (A) Cxcl9, (B)
Cxcl10, (C) Ccl19 and (D) Ccl21 was analyzed by quantitative PCR. The graph
represents the average of data from 2 independent experiments with 3 mice/group for
each experiment. Unpaired Student’s t-test: (*) = p < 0.05.
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Figure 22: NK cells control CPXV replication in CXCR3-deficient mice.
Age and sex matched CXCR3-deficient and C57BL/6 mice were injected IP with 200µg
control (mAR) or PK136 antibody 2 days prior to infection. (A) NK cell depletion was
confirmed in the non-draining LN at 3 dpi. Quantitative PCR was used to assess viral
burden in the (B) LNs, (C) lungs (D) and spleens. CPXV copy number was normalized to
$-actin copy numbers and then multiplied by 1000. Symbols indicate individual mice and
lines indicate the mean. N= 4 to 7 mice/group were analyzed for each time point.
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Figure 23: Macrophage depletion does not impact CPXV replication.
Five days prior to infection, C57BL/6 mice were treated in both rear footpads with 50µL
of either PBS- or clodronate-loaded liposomes. Quantitative PCR was used to assess viral
burden in the (A) LNs, (B) lungs (C) and spleens at 3 dpi. CPXV copy number was
normalized to $-actin copy numbers and then multiplied by 1000. Symbols indicate
individual mice and lines indicate the mean. N= 5 mice/group were analyzed for each
time point.
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CHAPTER 6:
Comparison of Cowpox Virus and Vaccinia Virus Footpad Infection
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Vaccinia virus has been used extensively as a prototypical model for
orthopoxviral infection in both in vitro and in vivo studies. To better understand whether
CPXV acts like a typical or abnormal orthopoxvirus for NK cell recruitment studies, we
used VV as a control. This chapter describes the host response to VV footpad infection,
with particular regard to NK cell recruitment.

Vaccinia Virus Effectively Infects Both the Draining LN and Spleen Following
Footpad Inoculation.
Viral spread and replication following CPXV or VV infection was similar, but
had distinct differences. When VV was inoculated in the footpads of C57BL/6 mice using
the same dose used for CPXV infections, VV spread to and replicated in the draining LN.
Titers for both viruses increased with similar kinetics between 1 and 3 dpi (Figure 24A).
However, following VV infection LN titers did not reach the same levels and resolved
faster than titers following CPXV inoculation. Titers were reduced to the limit of
detection by 6 dpi following VV infection whereas CPXV titers were not resolved until
9dpi. Thus CPXV was capable of surviving and replicating longer in the draining LN
than VV. Additionally, no titers were found for either virus in the liver by traditional
plaque assays (data not shown).
While productive infection of the draining LN appeared to be similar when
comparing the two viruses, the same was not true for spread to the spleen. Following VV
inoculation, titers were found above the limit of detection in the spleen 2 dpi whereas
titers were barely above or were at the limit of detection following CPXV inoculation
(Figure 24B). In addition, VV replicated in the spleen, peaking somewhere between 3 and
6 dpi reaching titers 2-logs greater than the limit of detection. Titers were decreased at 6
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dpi but we did not determine the day at which VV infection resolved. Taken together,
these data show that CPXV and VV replicate similarly, though with different kinetics, in
the draining LN and that VV, but not CPXV, is capable of spreading to and replicating
within the spleen.

CPXV and VV Cause Similar Lymphocyte Population Expansion in the Draining
LN
Cowpox and Vaccina virus infection caused lymphadenopathy resulting from an
expansion of the same lymphocyte populations in the draining LNs following footpad
infection. Both macrophage and neutrophil populations were increased at early times
following VV and CPXV inoculation (Figure 25A, 25B). The total neutrophil population
expansion was equivalent following either orthopoxviral infection but increase in the
macrophage population was slightly greater following VV inoculation at all time points
observed. In agreement with data generated following CPXV infection, following VV
infection we found little to no increase in the migratory DC population but an expanded
LN resident DC population (Figure 25C, 25D). We also observed large increases in both
T and B cell numbers, again with the total populations being larger following VV
inoculation (Figure 25E, 25F). Most importantly, we determined that there was a large
increase in the NK cell population following VV inoculation, which occurred with
slightly faster kinetics and persisted for a similar length of time following CPXV
infection (Figure 25G). All together, these data suggest that CPXV and VV prime similar
recruitment responses of lymphocytic populations, though VV may less efficiently inhibit
recruitment of lymphocyte populations resulting in a faster and more robust expansion of
macrophages, NK and T cells.
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When we examined the surface phenotype of NK cells found in the draining LN
following VV footpad inoculation, we found that they expressed markers typical of
splenic but not thymic NK cells. NK cells isolated from the spleen and draining LN
displayed identical expression of Mac-1 (CD11b), DX5, L-selectin (CD62L), NKG2D,
the Ly49 family (ADCIFH) and CD94 (Figure 26A-F). Similar to following CPXV
infection, expression of Mac-1 (CD11b) and L-selectin (CD62L) was different on NK
cells isolated from the non-draining and draining LN. Again, markers of thymic NK cells
were not found on NK cells isolated from the draining LN following VV infection
(Figure 26G, 27H). NK cells isolated from the draining LN following either CPXV or
VV infection expressed the same markers with the same intensity as NK cells derived
from the spleen, suggesting that the same subset of NK cells are being recruited
following either infection. These data suggest that the NK cell population in the draining
LN was recruited rather than the result of in situ proliferation.

NK Cells Are Recruited by the Same Mechanism Following Infection With Either
CPXV or VV
In agreement with the data generated following CPXV inoculation, VV also
induced NK cell expansion in a pertussis toxin sensitive manner. When we transferred
NK cells pre-treated with PBS in vitro into congenic mice, we found that these cells were
again accumulated over time in the draining LN following VV inoculation. Recruitment
of PBS pre-treated adoptively transferred NK cells appeared stronger following VV
infection than CPXV infection, as total cell numbers of these transferred NK cells were
greater at both 2 and 3 dpi following VV infection (Figure 27A, 27B). When NK cells
that had been pre-treated in vitro with pertussis toxin were co-transferred at the same
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time, they did not accumulate in the draining LN. Taken together, these data indicate that
NK cells recruitment was pertussis toxin sensitive and therefore required GPCRs
following both CPXV and VV infection.
When examining chemokine transcripts in the draining LN following VV
infection, we observed differential upregulation of some chemokine transcripts. Some
transcripts we observed to be up-regulated following VV but not CPXV inoculation
including Cxcl1, Cxcl2 and Cxcl5 at 1 dpi (Figure 28). These chemokines have been
implicated to affect neutrophils trafficking (141-143). It also appeared that Ccl24, which
has been shown to be important in eosinophils, basophils, and T cells (144), was
expressed earlier and then diminished more immediately following VV infection,
whereas CPXV induced prolonged expression of this transcript. There were also
differences in the abundance of transcripts for Ccl20, which has been shown to be
important a variety of lymphocytes including T cells, NKT cells and activated B cells,
which appeared to have a delay in expression following VV infection. These data indicate
that there is up-regulation of additional chemokines during VV infection that were not
observed following infection with CPXV.
Expression of chemokine transcripts up-regulated during VV infection was fairly
similar to that following CPXV infection. However, there were several important
differences in the intensity of chemokine up-regulation following CPXV and VV
infection. When examining transcripts for Ccl2 and Ccl7, we observed more abundant
transcripts following VV infection at all time points observed in comparison to CPXV
infection. Also, the IFN-! induced transcripts Cxcl9, Cxcl10, and Cxcl11 were more
highly induced and with faster kinetics following VV inoculation. Meanwhile, some
transcripts, such as those for Ccl3 and Ccl4, were nearly identical following either
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infection. The inflammatory chemokine transcript expression profile corresponded highly
with the larger increase in lymphocyte populations following VV infection in the draining
LN. These data again suggest that CPXV better inhibits the inflammatory response
including inflammatory chemokine expression than VV. This may permit a faster and
more robust accumulation of lymphocytes in the draining LN following VV inoculation.
To determine whether recruitment of NK cells following VV infection required
the same chemokine receptors as following CPXV infection, we examined NK cell
recruitment in chemokine receptor-deficient mice. In mice deficient for either CCR2 or
CCR5, there was a slight defect at 2 dpi but at 3 dpi NK cell recruitment was equivalent
in wild-type and chemokine receptor-deficient mice following VV infection (Figure 29A,
29B). These data were comparable to the requirement for CCR2 and CCR5 following
CPXV infection at 3 dpi. Mice that were deficient for CXCR3 showed a defect in NK cell
recruitment at both 2 and 3 dpi following both CPXV and VV infection (Figure 29C). As
expected, NK cell recruitment following VV, like CPXV infection, required NK cell
intrinsic expression of CXCR3 during adoptive transfer experiments (Figure 29D). These
data suggest that NK cells required similar chemokine receptors for recruitment
following infection with either CPXV or VV, providing further evidence that the same
NK cell population is recruited using related mechanisms following infection with either
orthopoxvirus.

Upstream Signaling Appears to Be Comparable Following Either CPXV or VV
Infection
As discussed in Chapter 5, we initially hypothesized that DCs were important for
NK cell recruitment following orthopoxviral infection. It appeared that DC populations
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were fairly equivalently following either CPXV or VV infection, with a slight elevation
in total resident DC numbers following VV infection at 6 dpi. However, this time point is
well beyond the peak of NK cell expansion in the draining LN. Concurrent to testing the
requirement for DCs upstream of CPXV infection, we also examined if DCs could
complement NK cell trafficking defects following VV infection in DC depleted mice.
Again we saw a defect in trafficking of injected BMDCs when VV concurrently injected
in the CD11c-DTR depleted mice (Figure 30A, 30B). Interestingly, the defect in DC
trafficking in the presence of VV was not observed in the C57BL/6 mice. Additionally,
even with some DCs trafficking to the draining LN, recruitment of NK cells was not
observed when BMDCs were co-injected in the CD11c-DTR mice (Figure 30C). These
data further indicate that DCs are not sufficient for recruitment of NK cells following
both CPXV and VV infection.

Discussion
Here we demonstrate that similar lymphocyte populations accumulate in the
draining LN during both CPXV and VV infection. There was a trend towards a more
robust recruitment of some but not all lymphocytes following VV infection suggesting
that CPXV inhibits lymphocyte recruitment more than VV. This increased lymphocyte
recruitment correlated with the induction of more inflammatory chemokine transcripts
during VV infection. The NK cell population expanded with faster kinetics following VV
infection, but the mechanism of recruitment and origin of recruited cells was the same.
Although, it has been well established that VV can subvert the immune system,
immunocompetent hosts routinely clear infection. While VV has been used extensively to
study immunomodulation of the host immune system by orthopoxviruses, it does not
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contain the extensive range of immunomodulatory ORFs found in CPXV (16, 23, 24).
While CPXV and VV share many homologous ORFs responsible for the viral life cycle
and immunomodulation, CPXV encodes many completely unique ORFs, mostly in
regions of its genome associated with immunomodulation and host adaptation. Therefore,
it was important to determine if the immune response to both viruses was similar or if
CPXV was more immunosuppressive as a consequence of these unique ORFs. We
assessed viral titers, viral spread and lymphocyte recruitment to the draining LN
following infection of mice with both viruses. Our data thus far indicate that CPXV and
VV very similarly recruited lymphocytes and replicated to similar titers following
infection.
In contrast to CPXV footpad infection, VV was capable of spreading to and
replicating within the spleen. This raises the possibility that VV may spread to other
distant sites from the draining LN, but a systematic survey of other organs has not been
performed. The increased viral spread of VV was surprising given the induction of a
more robust recruitment of lymphocytes following VV infection and because viral titers
in the LN did not reach the same levels as titers following CPXV infection. Secondary
viral spread is thought to follow sufficient replication in a primary organ, therefore
although viral burden in the draining LN following VV infection did not reach levels
found following CPXV infection, it was sufficient for viral spread. One possible
explanation for increased viral dissemination is that VV may have a broader cellular
tropism than CPXV. Once a few viral particles enter the circulation or the lymph, they
could establish productive foci of infection elsewhere, such as the spleen. However, this
hypothesis seems unlikely as CPXV has been shown to have one of the broadest host
ranges of the orthopoxviruses and therefore the ability to infect many different host cells
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(145). An alternate hypothesis is that VV recruits a lymphocyte population that is not
recruited following CPXV that traffics from the infected LN to the spleen. It is currently
unclear why VV, but not CPXV, is able to spread to and replicate within the spleen.
Although both CPXV and VV caused lymphadenopathy and influxes of the same
types of lymphocytes, VV stimulated an earlier and sometimes greater expansion of some
lymphocytes, including macrophages, NK cells and T cells. These results suggest that
CPXV more strongly attenuated inflammatory lymphocyte recruitment than VV,
particularly at early times following infection. Again, transcriptional profiles of
inflammatory chemokines lend support to this hypothesis, including expression of Ccl24,
Cxcl1, Cxcl2, and Cxcl5 that was only seen following VV infection. CXCL1, CXCL2 and
CXCL5 all bind only CXCR2, which has been implicated in neutrophil recruitment
following infection with several bacterial pathogens (141-143). Additionally, as
macrophages and neutrophils secrete CXCL1 and CXCL2, the expression of these
chemokines and subsequent recruitment of additional macrophages and neutrophils could
be acting in a positive feedback loop. Eosinophils express CCR3 (144), the receptor for
CCL24. However we did not examine this population so it is unknown whether it is
differentially recruited. While CCL24 is important during parasitic infections and renders
CD4+ T cells more sensitive to human immunodeficiency virus infection, its role
following orthopoxvirus infection has not been determined (146, 147). In addition,
chemokine transcripts that have been previously implicated in NK cell recruitment
following CPXV and other bacterial and viral pathogens, including Ccl2, Ccl7, Cxcl9,
Cxcl10, and Cxcl11, also had higher induction following VV infection of the draining
LN.
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Despite these slight differences, it appeared that the course of infection following
either CPXV or VV was very similar. There was a notably slight delay in NK cell
recruitment at early times following CPXV infection. NK cells isolated from the draining
LN following infection with CPXV and VV had identical expression of NK cell surface
markers which were typical of splenic NK cells. We observed a slight defect at 2 dpi in
the CCR2 and CCR5 defect following VV infection, which may be linked to the high
levels of Ccl2 induction. Again, NK cell recruitment did not appear to occur in a CCR2or CCR5-dependent manner at 3 dpi, but in a CXCR3 cell intrinsic manner for both
viruses. Overall, it appears that though VV recruitment of lymphocytes was more robust
and faster, CPXV infection was similar to the prototypical model of orthopoxviral
infections. We can therefore conclude that NK cell recruitment following infection with
orthopoxvirus family members is likely to be mediated by similar or identical
mechanisms.
After footpad inoculation with either CPXV or VV, lymphadenopathy resulted
from similar recruitment of lymphocyte populations. These data also indicated that
recruitment of the splenic NK cells to the draining LN is mediated by same chemokines
and chemokine receptors. Additionally, DC complementation was also insufficient to
restore NK cell trafficking suggesting an upstream requirement for macrophages in NK
cell trafficking following VV infection. Taken together, these data indicated that CPXV
and VV induce a very similar host response following footpad infection.
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Figure 24: VV establishes infection in the draining LN and spleen following footpad
inoculation.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu of VV in the footpad
and at indicated time points, organs were removed and viral titers were assessed in the
draining LN (A) and spleen (B) by plaque assay. Dotted lines indicate the limit of
detection by the assay. Symbols indicate individual mice and the mean and SEM are
depicted. N= 4 to 5 mice/group were analyzed for each time point.
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Figure 25: Comparative kinetics of innate and adaptive lymphocyte expansion
following CPXV or VV footpad infection.
Age and sex matched C57BL/6 mice were inoculated in the footpad with1.5x106
pfu/mouse of VV and at indicated time points, lymphocytes from the non-draining and
draining LNs were isolated. (A-D) LNs were diced and incubated in Liberase TL before
lymphocytes were isolated, stained and analyzed by flow cytometry. (E-G) Lymphocytes
were isolated, stained and analyzed by flow cytometry and (A) total macrophages
(F4/80+CD11b+), (B) total neutrophils (Ly6G+SSC+), (C) total migratory DCs
(CD11c+MHCIIhigh), (D) total LN resident DCs (CD11c+MHCII+), (E) total T cells
(CD3+CD19-NK1.1-), (F) total B cells (CD19+CD3-NK1.1-) and (G) total NK cells
(NK1.1+CD3-CD19-) were identified. (A-F) Graphs depicting the average of 3
independent experiments are shown. (G) The graphs depict average of n=6 independent
experiments (18 hpi), n=14 independent experiments (1 dpi), n=3 independent
experiments (36hpi), n=8 independent experiments (2 & 3 dpi), and n=2 independent
experiments (6 & 9dpi).
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Figure 26: NK cells isolated from the draining LN following VV infection express
markers of splenic but not thymic NK cell subsets.
Age and sex matched C57BL/6 mice were infected as before and lymphocytes from the
spleen, thymus, draining and non-draining LN were isolated 1 dpi and surface stained.
Following identification of NK cells (NK1.1+CD3-CD19-), expression of (A) Mac-1
(CD11b) (B) pan-Ly49 family receptors (Ly49ADCIFH), (C) L-selectin (CD62L), (D)
DX5 (CX5), (E) CD94, (F) NKG2D, (G) IL-7R" (CD127) and (H) integrin "E (CD103)
was determined. Surface staining remained the same when observing NK cells isolated
from these organs at 2 and 3 dpi.
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Figure 27: NK expansion in the draining LN is pertussis toxin sensitive following
VV infection.
Splenocytes isolated from congenic C57BL/6 (CD45.2) and B6.LY5.2 (CD45.1) mice
were pre-treated in vivo with PBS or pertussis toxin for 2 hours at 37°C, 5% CO2 before
being washed, CFSE labeled, mixed and co-injected IV into C57BL/6 mice. Immediately
following adoptive transfer, the mice were infected with 1.5x106 pfu of VV in the
footpad. At the indicated time points, LNs were harvested and NK cells (NK1.1+CD3CD19-) were identified. Host NK cell recruitment (CFSE-) (A) or donor NK cell
recruitment (CFSE+) (B) is shown over time. Data are representative of 2 independent
experiments.
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Figure 28: Inflammatory chemokine transcripts are up-regulated following VV
infection.
RNA transcript levels were assessed in C57BL/6 mice infected with 1.5x106 pfu of VV in
the footpad at indicated time points by multiplex gene expression analysis. LNs from 3
independently infected mice were isolated and lysates from either the non-draining or
draining LN were generated, run in triplicate, and chemokine transcripts normalized to
the control Hprt1 transcript for each sample. The fold change indicated in each square
depicts the average transcript level in the draining LN relative to the non-draining LN.

121

3  dpi

2  dpi

1  dpi

3  dpi

2  dpi

1  dpi

Cxcl1  (Groα) 9.67 2.89 1.40

Ccl1  (I-309) 0.33 0.26 0.59

Cxcl2  (Groβ) 17.38 0.85 1.10

Ccl2  (MCP-1) 18.94 9.09 11.44

Cxcl3  (Groγ) 1.02 0.30 0.31

Ccl3  (Mip-1a) 5.16 4.06 6.01

2.9

Ccl4  (Mip-1b) 7.97 5.86 4.74

Cxcl9  (Mig) 12.95 6.26 3.72

Ccl5  (RANTES) 0.58 0.70 0.39

Cxcl10  (IP-10) 19.72 19.24 10.81

Ccl6  (C10/MRP1) 2.88 1.19 1.10

Cxcl11  (I-TAC) 35.24 18.9 39.54

Ccl7  (MCP-3) 14.56 5.45 6.86

Cxcl12  (SDF-1α/β) 0.21 0.23 0.08

Ccl8  (MCP-2) 0.47 0.84 0.18

Cxcl13  (BLC/BCA-1) 0.58 0.59 0.47

Ccl9  (MRP-2/MIP-1γ) 1.92 1.85 1.64

Cxcl14  (BRAK/bolekine) 1.95 0.42 0.87

Ccl11  (Eotaxin) 3.17 0.94 0.95

Cxcl15  (Lungkine/WECHE) 0.16 0.10 0.15

Ccl12  (MCP-5) 1.99 1.46 0.82

Cxcl16  (None) 0.75 0.59 0.41

Ccl17  (TARC) 0.99 0.28 0.16

Xcl1  (Lymphotactin) 5.07 3.96 2.30

Ccl19  (MIP3β/ELC) 1.30 0.59 0.27

Cxcl5  (ENA-78) 11.31 2.22

Ccl20  (MIP-3α/LARC) 1.38 5.90 12.77
Ccl21a  (6CKine/SLC) 0.31 0.28 0.10
Ccl22  (MDC) 0.88 0.37 0.25
Ccl24  (Eotaxin-2/MPIF-2) 11.77 0.83 0.97
Ccl25  (TECK) 0.88 0.72 0.58
Ccl27a  (CTACK) 0.78 0.44 0.44
Ccl28  (MEC) 2.02 0.70 1.30

Figure 29: NK cell recruitment occurs in the absence of CCR2 and CCR5 but
intrinsically requires CXCR3 expression following VV infection.
Age and sex matched C57BL/6 and (A) CCR2-deficient, (B) CCR5-deficient or (C)
CXCR3-deficient mice were infected with 1.5x106 pfu of VV. At indicated time points,
lymphocytes from the non-draining and draining LNs were isolated, stained and analyzed
by flow cytometry. Total NK cells (NK1.1+CD3-CD19-) were identified. The graph
depicts the average of 3 independent experiments. (D) C57BL/6 (CD45.1) and CXCR3-/(CD45.2) splenocytes were isolated and enriched by negative selection before being
CFSE labeled, mixed and co-transferred intravenously into C57BL/6 mice. 1 day after the
transfer, mice were infected as before and NK cell populations were examined at
indicated time points. To analyze the recruitment in this system, the total number of
recruited wild-type or chemokine knockout NK cells at 2 and 3 dpi were compared
relative to the initial time point at 1 dpi. A representative result of 3 independent
experiments is shown.
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Figure 30: BMDCs do not complement NK cell recruitment defects seen in CD11cDTR transgenic mice following VV infection.
Age and sex matched C57BL/6 and CD11c-DTR transgenic mice were treated with 5
ng/g body weight of diphtheria toxin 1 day prior to injection of BMDCs and VV
infection. Flt3L BMDCs were generated in vitro, labeled with CFSE and injected into the
top of the foot while CPXV was injected in the bottom of the footpad of diphtheria toxin
treated CD11c-DTR mice and C57Bl/6 mice. LNs were isolated 1 day later and treated
with Liberase TL following which lymphocytes were isolated, stained and analyzed by
flow cytometry. (A) Percent and (B) total donor derived BMDCs
(CD11c+MHCIIhighCFSE+) and (C) total NK cells (NK1.1+CD3-CD19-) were assessed
and graphed. The graph represents 1 mouse for BMDC injected alone and CXPV injected
alone while BMDC and CPXV injected in the same foot represent the average 2 mice for
both CD11c-DTR and C57BL/6 mice.

125

C57BL/6

DC  +CPXV

CPXV

C57BL/6
DC  +CPXV

CPXV

DC

DC  +CPXV

CPXV

DC

Total  Donor  Derived  DCs

C57BL/6

DC

DC  +CPXV

CPXV

DC

Total  NK  Cells

DC  +CPXV

CPXV

DC

DC  +CPXV

CPXV

DC

%  Donor  Derived  DCs

A
NDP

35

30

DP

25

20

15

10
5

0

CD11c-DTR+/+

B
NDP

500

DP

400

300

200

100

0

CD11c-DTR+/+

C
NDP

20000
DP

15000

10000

5000

0

CD11c-DTR+/+

CHAPTER 7:
Cowpox Virus Mediated-Inhibition of NK Cell Activation
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During the initial analysis of NK cell recruitment, it became apparent that NK
cells recruited to the draining LN following CPXV infection were not producing IFN-!.
This cytokine is an important mediator of the inflammatory response and contributes to
priming of a TH1 adaptive immune response (54, 107, 131, 137, 148). NK cells are one of
the major producers of IFN-! at early times following infection. This chapter describes
the inhibition of NK cells by CPXV in a footpad model of infection.

NK Cells Recruited by CPXV Do Not Produce IFN-!

One of the primary functions of NK cells aside from target cell lysis is production
of cytokines, including IFN-! which primes a TH1 T cell response (54, 107, 148). It was
demonstrated that following ECTV infection, NK cells producing IFN-! were recruited to
the draining LN at early times following infection (80, 81). With these studies informing
our experiments, NK cells recruited to the draining LN were examined for IFN-!
following CPXV footpad inoculation. Surprisingly, at no time point studied did we
observe NK cells producing IFN-! (Figure 31A). In contrast to this CPXV specific
finding, C57BL/6 mice inoculated with either VV or MCMV recruited IFN-! producing
NK cells in the draining LN (Figure 31A, 31B). Production of IFN-! peaked between 1
and 2 dpi for MCMV and between 2 and 3 dpi for VV, time points where there was no
IFN-! observed following CPXV infection.
Since it was possible that the lack of IFN-! production by NK cells following
CPXV infection may have been a consequence of insufficient infectious dose, we
examined a range of CPXV doses to determine if it was possible to induce IFN-!
production under any circumstances. However, IFN-! production by NK cells did not
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occur when mice were inoculated with a wide range of doses, from 3.75 x 103 pfu/mouse
to 3.75 x 106 pfu/mouse (Figure 32A). In contrast, we observed IFN-! producing NK
cells following infection with VV beginning at 3.75 x 104 pfu/mouse, with increased
IFN-! production directly correlating with increased infectious dose (Figure 32B). In
order to simultaneously study both NK cell recruitment and IFN-! inhibition by CPXV,
all subsequent experiments were performed using a dose of 1.5 x106 pfu/mouse.

Cytokine Production in the Draining LN Following CPXV and VV Infection
NK cells are one of the primary sources of early IFN-! production following
infection by a variety of pathogens. As IFN-! induced chemokines were found to be
responsible for NK cell recruitment at 2 and 3 dpi following CPXV infection, we
measured cytokine protein levels in the draining LN by cytometric bead array. We found
that following infection with VV, IFN-! was produced at constant levels between 1 and 3
dpi in the draining LN and diminished between 3 and 6 dpi (Figure 33A). In contrast,
CPXV did not stimulate production of IFN-! to the same extent as VV until 3 dpi.
However, CPXV induced higher levels of IFN-! than VV at 6 dpi. IFN-! was reduced by
9 dpi infection for both viruses and only following CPXV infection did we see minimal
levels of IFN-! in the draining LN at 12 dpi. These data indicate that infection with VV
induced a lower IFN-! response at early times following infection that contracted more
quickly, coinciding with earlier resolution of VV titers in the draining LN. Meanwhile,
CPXV induced a greater but delayed IFN-! response that was sustained longer and also
corresponded with resolution of CPXV titers.
Following CPXV and VV infection, cytokine production closely correlated with
the course of infection by either virus. Levels of IL-6, an inflammatory cytokine (149),
129

were similar following infection with either virus at 1 dpi, but differed at subsequent time
points (Figure 33B, 33C). Levels of IL-6 increased following CPXV infection beginning
at 2 dpi and peaking between 6 and 9 dpi. In contrast, following VV infection, levels of
IL-6 remained fairly constant at all time points observed. CPXV in vivo infection induces
of high levels of IL-10, an anti-inflammatory cytokine (39, 150). Following CPXV
footpad infection, we observed sustained high levels of IL-10 through 6 dpi. In
comparison, IL-10 levels following VV were lower at most time points observed, peaking
at 1 dpi and not detected at 6 dpi. Protein production of MCP-1, otherwise known as
CCL2, was also measured following infection with CPXV and VV. VV induced high
CCL2 protein levels at 1 through 6 dpi while CCL2 protein levels were minimal
following CPXV infections at these times (Figure 33D). Detection of high levels of
CCL2 did not occur until 9 dpi following CPXV, a time point where CCL2 production
was declining following VV infection. Taken together, these data suggest that infection
with CPXV leads to expression of anti-inflammatory cytokines at early times following
infection, lending further evidence in support of our hypothesis that CPXV more
completely inhibits the immune response than VV.

Activation of NK Cells is Incomplete Following CPXV Infection
The lack of IFN-! production by NK cells suggested that CPXV subverted NK
cell function. Seemingly in contrast to these findings, we observed an increased viral
burden in the draining LN in the absence of NK cells, suggesting anti-viral NK cell
functionality in spite of IFN-! inhibition. We therefore examined whether recruited NK
cells were activated following infection with CPXV. Examining the surface expression of
several activation markers, we observed that NK cells isolated from the draining LN had
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little to no expression of CD69 or CD25 (Figure 34). When examining NK cells isolated
from the draining LN following VV infection, we observed differential expression of
surface activation markers. At 1 dpi, CD69 was up-regulated but surface expression
decreased over time while the inverse was observed for CD25 (Figure 34). These results
suggested CPXV infection inhibited the activation of NK cells in the draining LN.
Despite this lower expression of activation markers on NK cells following CPXV,
systemic depletion of NK cells resulted in increased viral burden. In order to measure NK
cell function, we examined the induction of granzyme B, an effector molecule in targeted
cell lysis. In contrast to IFN-! production, NK cells isolated from the draining LN
following both CPXV and VV infection produced higher levels of granzyme B than NK
cells isolated from the non-draining LN when examined by flow cytometry (Figure 35).
These data suggest that since NK cells produced granzyme B, resistance to CPXV
infection may be mediated through cell lysis.

NK cell Production of IFN-! is Inhibited by CPXV Infection
We had several hypotheses regarding the differential ability of NK cells to
produce IFN-! following CPXV or VV infection. The first hypothesis was that VV but
not CPXV encoded a molecule that was recognized by an activating NK cell receptor,
akin to m157 mediated activation following MCMV infection (57). Alternately, it was
also possible that CPXV, having a larger genome than VV and therefore a greater number
of potentially inhibitory ORFs, contained one or more unique ORFs that inhibited IFN-!
production by NK cells. Additionally, neither of these hypotheses is mutually exclusive,
and it was possible that VV produced an activating molecule and CPXV produced an
inhibitory molecule.
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To determine if CPXV was inhibiting IFN-! production by NK cells, we
employed a co-infection model where C57BL/6 mice were injected with either CPXV or
VV or a mixture of CPXV and VV at a 1:1 ratio. NK cells isolated from the draining LNs
of co-infected mice did not produce IFN-!, similar to following CPXV infection (Figure
36A, 36B). These data indicated that NK cell production of IFN-! was being inhibited by
CPXV infection. To ensure that VV was replicating following co-infection, we used
CPXV&203-GFP, where GFP has been inserted in the place of CPXV203. Following coinfection, LNs were titered and plaques that expressed GFP, indicating CPXV replication,
were counted prior to fixing and staining all plaques on the monolayer allowing
differentiation between CPXV and VV plaques. At early time points, we observed that
most plaques were GFP positive, indicating mostly CPXV replication (Figure 36C).
However, 2 and 3 dpi, we observed plaques that did not express GFP indicating active
VV replication at later times following co-infection. These data indicate that NK cells
production of IFN-! is actively inhibited by CPXV infection, even during co-infection
with VV.
Next we examined the effect of varying the co-infection ratio to determine
whether CPXV mediated inhibition of IFN-! production by NK cells could be overcome.
When the amount of CPXV in the co-infection was lowered, there was an intermediate
restoration of IFN-! production by recruited NK cells (Figure 37A, 37B). However, when
the amount of CPXV was maintained at the normal dose and the dose of VV was
increased, recruited NK cells were not capable of producing IFN-! (Figure 37A, 37B).
These data suggest that CPXV is producing an inhibitory molecule that at 1.5x106
pfu/mouse is sufficient to inhibit NK cell production of IFN-!, even in the presence of
overwhelming VV infection. However, since IFN-! production was less inhibited when
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using a decreased dose of CPXV during the co-infection, it appears that the putative
CPXV inhibitory molecule can be titrated. As these data suggested that CPXV inhibition
could be overcome in vivo, we attempted to stimulate NK cells ex vivo with PMA and
ionomycin. Treatment with this strong stimulus resulted in production of IFN-! by NK
cells (Figure 37C). These data indicated that CPXV inhibition can be overcome both in
vivo by limiting the CPXV infectious dose in a co-infection model and ex vivo with a
strong stimulus.

Inhibition of IFN-! Production in NK Cells is Complex and Multifactorial
Next, we performed genomic comparisons between CPXV Brighton Red, ECTV
Moscow, and VV Western Reserve to identify likely candidate ORFs in CPXV which
might be responsible for the inhibition of IFN-! production by NK cells. Since footpad
infection with VV and ECTV induces the recruitment of IFN-! producing NK cells (80,
81), we chose to exclude CPXV ORFs with homologues in VV or ECTV. Based on a
nucleotide sequence identity threshold of 80%, we determined that there were 36 unique
CPXV specific ORFs (Table 2). The identification of CPXV012, CPXV018 and
CPXV203 in our screen, which have previously been demonstrated to be unique CPXV
ORFs (29, 30, 85) supported the validity of our screen.
To rule out ORFs not involved in inhibition of IFN-! by NK cells, we first tested
viruses deficient for ORFs that had previously been implicated in the down-regulation of
MHC class I or could bind in vitro with high affinity to the NK activating receptor,
NKG2D. We found that infection with CPXV&012, CPXV&018, and CPXV&203,
induced recruitment of NK cells to draining LNs in numbers equivalent to wild-type
CPXV infection (Figure 38A, 38C, 38E). However, these NK cells still failed to produce
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IFN-!, indicating that these ORFs were not responsible for the inhibition of NK cells
(Figure 38B, 38D, 38F).
Given the large number of CPXV specific ORFs identified in our screen, it
seemed impractical to generate single mutant deletion viruses for all 36 ORFs and
systematically examine them for an IFN-! inhibition phenotype. Instead, we employed
large deletion mutants generated by a collaborator to screen many ORFs at the same time.
One of these mutants, A587 contains two deletions, one within each terminal region of
the CPXV genome. ORFs 3-9 and 222-227 are missing from the A587 mutant and 7 of
the CPXV unique ORFs fall within these deletions including ORF 3, 7, 8, 9, 222, 223,
and 224. When the A587 mutant was used to infect mice, we found similar recruitment of
NK cells to the draining LN (Figure 39A) but no IFN-! producing NK cells (Figure 39B).
Therefore the inhibition of NK production of IFN-! was unchanged and we discounted
those 7 predicted ORFs.
We next examined the A518 mutant, which has one large deletion of ORFs 11-36,
including 7 unique to CPXV which were identified in our genomic screen: 12, 13, 17, 18
19, 20 and 31f. Again, recruitment of NK cells to the draining LN was comparable using
the A518 mutant to recruitment following either CPXV or VV (Figure 40A). When we
infected using this virus, we found a partial restoration of IFN-! production (Figure 40B).
The expression of CD69 was also observed at later time points after infection and
appeared to correlate with the induction of IFN-! expression (Figure 40C). In contrast,
expression of CD25 did not appear to correlate with IFN-! expression following CPXV
and A518 mutant infection (Figure 40C). Given the partial restoration of IFN-! and CD69
expression, we postulated that the inhibitory ORF lay within this deletion.
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To determine whether a particular ORF was responsible for the lack of IFN-!
inhibition in the A518 mutant, we used two viruses with deletions within the A518
deleted region: one lacking ORFs 18-21 and another lacking ORFs 22-36. While both of
these viruses recruited NK cells similarly to wild-type CPXV (Figure 41A), they also
both recruited NK cells that produced intermediate IFN-! levels similar to the A518
recruited NK cells (Figure 41B). These data suggest that CPXV inhibition of IFN-!
production by NK cells was the product of at least two ORFs in the 11-36 region, making
inhibition multifactorial.

Discussion
Here we demonstrate that CPXV recruited NK cells were not fully mature, as
demonstrated by decreased expression of surface maturation molecules and the inability
to produce IFN-!. CPXV recruited NK cells retain the ability to produce granzyme B and
limit viral replication in the draining LN, and are therefore still functional despite
incomplete maturation. Our data indicate that incomplete NK cell maturation is the
product of active inhibition by CPXV. This inhibition is complex and multifactorial since
it is partially abrogated during infection with CPXV mutants that contain large genomic
deletions.
NK cells have both the capacity to directly lyse target cells and to induce
cytokines which shape the adaptive immune response. Following CPXV infection, NK
cells kill infected cells through direct lysis mediated through granzyme B, but are
inhibited for IFN-! production. One hypothesis which may explain this phenotype is that
CPXV can inhibit only one of multiple activation signals that are required to stimulate
different NK cell functions (151). Supporting this hypothesis, NK cells can express small
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amounts of Klrg1 and normal granzyme B following CPXV infection. CD69 and IFN-!
are most highly expressed at early times after infection with VV, and both
correspondingly decrease as the infection progresses. In either the A518 mutant or the coinfection model where a partial restoration of IFN-! production was observed, a slight
increase in CD69 is also observed. These data suggest that the same signal may be
responsible for CD69 expression and IFN-! induction while induction of granzyme B
may occur following an alternate signal. Additionally, when examining expression of
CD25, we observed that it does not appear to be linked to either IFN-! or granzyme B
expression, suggesting yet another signal might be important for NK cell survival. NK
cells can respond to a variety of signals including type I IFNs, other pro-inflammatory
cytokines and direct receptor ligation. Therefore it is possible that integration of multiple
disparate signals result in different functionality of NK cells.
There are several alternate hypotheses that could explain this NK cell activation
phenotype. It is also possible that NK cell stimulation following CPXV infection is
interrupted and the phenotype results from partial activation by an immediate early or
early CPXV ORF(s) before inhibition occurs. Additionally, NK cells can be directly
infected by VV(152, 153), so it is possible they may also be infected by CPXV, limiting
their activation. At this time, we have not examined CPXV tropism, but direct infection
of NK cells by CPXV is an intriguing idea. Finally, incomplete activation of NK cells
could result from a combination of any of these hypotheses.
When examining cytokine protein expression by multiplex analysis, we found a
close correspondence between CPXV or VV infection and cytokine induction. Following
VV infection, there was induction of both IL-6 and IFN-!, both pro-inflammatory
cytokines that may stimulate more rapid recruitment of inflammatory lymphocytes and
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therefore early resolution of VV titers in the draining LN. In contrast, CPXV induced
expression of these inflammatory molecules is delayed. Instead CPXV infection
increased early expression of IL-10, which is known to be inhibitory towards maturation
of DCs and macrophages and inhibit function of T and NK cells (150, 154). These
cytokine expression profiles indicate a more inhibitory nature of CPXV infection in the
draining LN.
Following CPXV infection IFN-! protein expression was observed in the draining
LN. Since we know that recruited NK cells are not responsible for production of this
IFN-!, another cell must be the source of this cytokine. The early expression of IFN-!
protein suggests that another innate lymphocyte may be responsible for its production.
Several innate lymphocytes have been implicated in very early production of IFN-!
including NKT cells and an innate CD8+ T cell population (131, 155). At this time, these
populations have not been examined in the context of our CPXV footpad infection. IFN-!
production continues to increase in the draining LN following CPXV infection, peaking
at 6 dpi, when adaptive CD8+ T cells could be responsible for its production. While
CPXV, like all orthopoxviruses, encodes an IFN-! binding protein, this protein has been
shown to be unable to bind murine IFN-! (156). Thus it is likely that the induction of
IFN-! helps control CPXV infection in the draining LN.
The co-infection experiments indicate that CPXV produces an inhibitory
molecule that dominates any potential VV derived activating molecule. Since coinfection of single cells is likely to be rare following injection with both CPXV and VV,
we speculated that the inhibitory molecule was either a surface expressed molecule or
secreted. If the inhibitory molecule was intracellular, then the cells infected with only VV
during co-infection would be expected to stimulate IFN-! production by recruited NK
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cells and intermediate production of IFN-! would be observed. However, the inhibition of
IFN-! was absolute at all time points observed following co-infection supporting our
hypothesis that the inhibitory molecule is surface expressed or secreted.
In attempts to address this hypothesis of extracellular inhibition, we varied the
ratio of CPXV and VV used during co-infection experiments. These experiments
indicated that the amount of CPXV present was the limiting factor for inactivation of NK
cells, again confirmed the dominance of the inhibitory molecule(s). Inhibitory molecules
are often dominant to activating molecules, examples of which can be found within NK
cell receptor signaling. NK cell inhibitory receptors that sense MHC class I on potential
targets cells strongly inhibit activation of NK cells and viruses have evolved to exploit
this interaction. They do so employing mechanisms including MHC class I mimicry and
stabilization of Qa-I/HLA-E to signal inhibitory NKG2/CD94 receptors (157-160). Thus
the strong inhibition of NK cell IFN-! production by CPXV could be overpowering any
potential ORF encoded by VV and future studies must be performed to determine if such
an activating ORF exists.
Our attempt to identify the inhibitory ORF expressed by CPXV resulted in
discovery of several mutants with intermediate IFN-! production, including the the A518
mutant, CPXV&18-21 and CPXV&22-36. These findings lead to several potential
hypotheses. First, it could be that there are multiple ORFs responsible for inhibition of
IFN-! production, located in this region that could be NK specific. Another possibility is
that CPXV lacking the inhibitory ORF is not capable of inducing IFN-! production to the
levels that VV does. Experiments designed to test both of these hypotheses will be
complicated by numerous non-NK specific inhibitory proteins encoded within the
terminal regions of the CPXV genome, including multiple cytokine-binding proteins.
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These data suggest that inhibition of IFN-! is multifactorial and will be difficult to dissect
using single deletion analysis.
Here we have examined the activation of NK cells following CPXV footpad
infection. Surprisingly, given increased viral burdens in systemically NK cell depleted
mice, NK cells recruited to the draining LN did not produce IFN-! or up-regulate
activation markers during CPXV infection. Control of viral replication may therefore
involve granzyme B mediated target cell lysis, as expression of granzyme B remained
unaffected following CPXV infection. Attempts to identify the CPXV ORFs responsible
for NK cell inhibition have only underscored the complex, multifactorial nature of NK
cell function, especially in the context of viral infection.
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Figure 31: CPXV infection inhibited production of IFN-! by NK cell recruited to the
draining LN.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms of CPXV or VV
or 8.5x104 pfu/ms MCMV and at indicated times, cells from the draining and nondraining LN were isolated and stained. Following extracellular staining, cells were fixed,
permeablized and intracellularly stained for IFN-!. Total IFN-! producing NK cells
(NK1.1+CD3-CD19-IFN-!+) cells following (A) CPXV, VV or (B) MCMV infection are
graphed. (A) The graph depict average of n=6 independent experiments (18 hpi), n=14
independent experiments (1 dpi), n=3 independent experiments (36hpi), n=8 independent
experiments (2 & 3 dpi), and n=2 independent experiments (6 & 9 dpi).
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Figure 32: VV infection but not CPXV infection stimulated NK production of IFN-!
in a dose dependent manner.
Age and sex matched C57BL/6 mice were infected with 3.75 x 103 pfu/mouse to 3.75 x
106 pfu/mouse of (A, C) CPXV or (B, D) VV. At indicated time points, cells from the
draining and non-draining LN were isolated and stained. Following extracellular staining,
cells were fixed, permeablized and intracellularly stained for IFN-!. (A, B) Percent and
(C, D) total IFN-! producing NK Cells (NK1.1+CD3-CD19-IFN-!+) cells following (A,
C) CPXV and (B, D) VV infection are graphed.
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Figure 33: Kinetic analysis of cytokine expression in the draining LN following
CPXV and VV infection.
Age and sex matched C57BL/6 mice were infected as before with CPXV or VV and at
indicated times, LNs were isolated and homogenized by bead beating in RPMI. Cytokine
production was measured using the mouse inflammation cytometric bead array. (A) IFN!, (B) IL-6, (C) IL-10 and (D) CCL2 (MCP-1) expression are graphed over time. The
graph depicts the average of n=4 to 5 independently infected mice (1, 2, 3, 6, and 9 dpi)
and n= 2 (CPXV) to 5 (VV) independently infected mice.
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Figure 34: Kinetic analysis of NK cell expression of surface activation molecules
following CPXV or VV infection.
Age and sex matched C57BL/6 mice were infected as before with CPXV or VV and at
indicate times, lymphocytes from the draining and non-draining LN were isolated and
stained. Following identification of NK cells (NK1.1+CD3-CD19-), surface expression of
CD69 and CD25 was determined. A representative result of 3 independent experiments is
depicted.
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Figure 35: NK cells produce granzyme B following CPXV and VV infection.
Age and sex matched C57BL/6 mice were infected as before and at indicated times,
lymphocytes from the draining and non-draining LN were isolated and stained. Following
extracellular staining, cells were fixed, permeablized and intracellularly stained for IFN-!
and granzyme B. Following identification of NK cells (NK1.1+CD3-CD19-), IFN-! and
granzyme production was assessed. A representative dot plot from 10 independent
experiments is shown.
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Figure 36: NK cells do not produce IFN-! following co-infection with CPXV and
VV.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms CPXV, VV or a
1:1 mixture of CPXV and VV. At indicated times, lymphocytes from the draining and
non-draining LN were isolated and stained. Following extracellular staining, cells were
fixed, permeablized and intracellularly stained for IFN-!. (A) Percent and (B) total IFN-!
producing NK cells (NK1.1+CD3-CD19-IFN-!+) for 4 independent experiments are
depicted. (C) C57BL/6 mice were injected with 1.5x106 pfu/ms CPXV&203-GFP, VV or
a 1:1 mixture of CPXV&203-GFP and draining LNs were titered on CV-1 monolayers.
GFP-expressing plaques were counted prior to crystal violet staining. Data represent the
average of 1 mouse from 2 independent experiments.

150

A
%  IFN-γ+  NK  Cells

20

CPXV  -  NDP
CPXV  -  DP
VV  -  NDP
VV-  DP
CPXV  +  VV  -  NDP
CPXV  +  VV-  DP

15
10
5
0

1

2
days  post  infection

3

B
Total  IFN-γ+  NK  Cells

8000

CPXV  -  NDP
CPXV  -  DP
VV  -  NDP
VV-  DP
CPXV  +  VV  -  NDP
CPXV  +  VV-  DP

6000
4000
2000
0
1

2
days  post  infection

  %  (CPXV-GFP+/Total)  Plaques

C

3

100
75
50
25
0
1

2
days  post  infection

3

Figure 37: Inhibition of NK cell IFN-! production can be overcome.
Age and sex matched C57BL/6 mice were infected with CPXV, VV or with 0.1:1, 1:1 or
1:10 mixtures of CPXV and VV. Lymphocytes from the draining and non-draining LN
were isolated and stained 1 dpi. Following extracellular staining, cells were fixed,
permeablized and intracellularly stained for IFN-!. (A) Percent and (B) total IFN-!
producing NK cells (NK1.1+CD3-CD19-IFN-!+) are graphed. The graph depicts the
average of data from 2 to 4 independent experiments. (C) C57BL/6 mice were infected
with CPXV and lymphocytes were isolated at 1, 2 or 3 dpi and stimulated with
PMA/ionomycin for 8 hours. Following identification of NK cells (NK1.1+CD3-CD19-),
IFN-! expression was assessed. A representative result of 4 independent experiments is
depicted.
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Table 2: ORFs found in CPXV but not ECTV or VV.
This table lists ORFs determined by comparing the genomes of CPXV-Brighton Red,
VV-Western Reserve, and ECTV-moscow strains using 80% identity threshold. The
screen identified 36 ORFs that were unique to CPXV-Brighton Red.
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Predicted Protein Information

CPXV ORF

1 or 2 predicted membrane spanning sequences 1, 3, 7, 47, 58, 63, 119a, 130, 160, 170, 192,
214, 224, 229
Ankryin domain

8, 17, 19, 220, 223

Secretory signal peptide

18, 170

Homologous to CMPX TLR inhibitor

9, 222

MHC I downregulation

12, 203

Galactose oxidase / transcriptional repression

13

Viral sensitivity to "-amanitin

10

no information

2, 31f, 51a, 78a, 96, 116, 152a, 216, 228
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Figure 38: The inhibition of IFN-! production by NK cells is unaffected in the
absence of CPXV012, CPXV018 and CPXV203.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type
CPXV, VV or (A) CPXV&012, (B) CPXV&018 or (C) CPXV&203. Lymphocytes from
the draining and non-draining LN were isolated and stained 1 dpi. Following extracellular
staining, cells were fixed, permeablized and intracellularly stained for IFN-!. NK cells
(NK1.1+CD3-CD19-) were identified and IFN-! expression was assessed. Both percent
and total IFN-! producing cells are depicted.
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Figure 39: The A587 mutant inhibits NK cell IFN-! production.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type
CPXV, VV or A587. Lymphocytes from the draining and non-draining LN were isolated
and stained 1 dpi. Following extracellular staining, cells were fixed, permeablized and
intracellularly stained for IFN-!. NK cells (NK1.1+CD3-CD19-) were identified and IFN! expression was assessed. (A) Percent and (B) total IFN-! producing NK cells
(NK1.1+CD3-CD19-IFN-!+) are graphed.
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Figure 40: NK cells activation is partially restored following infection with the A518
mutant.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type
CPXV, VV or A518. Lymphocytes from the draining and non-draining LN were isolated
and stained 1 dpi. Following extracellular staining, cells were fixed, permeablized and
intracellularly stained for IFN-!. (A) Percent and (B) total IFN-! producing NK cells
(NK1.1+CD3-CD19-IFN-!+) are graphed. Data from 5 independent experiments are
depicted. (C) Following identification of NK cells (NK1.1+CD3-CD19-), CD69 and CD25
surface expression was assessed. A representative result of 2 independent experiments is
depicted.
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Figure 41: CPXV inhibition of NK cell IFN-! production is control by multiple
ORFs.
Age and sex matched C57BL/6 mice were infected with 1.5x106 pfu/ms wild-type
CPXV, VV, A518, CPXV&018-021, or CPXV&022-036. Lymphocytes from the draining
and non-draining LN were isolated and stained 1 dpi. Following extracellular staining,
cells were fixed, permeablized and intracellularly stained for IFN-!. (A) Percent and (B)
total IFN-! producing NK cells (NK1.1+CD3-CD19-IFN-!+) are graphed. The graphs
depict the average of data from 3 to 5 independent experiments.
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Conclusions and Future Directions
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Cowpox Footpad Infection Provides a Relevant Model for Zoonotic Infection
Orthopoxviruses cause zoonotic infection and several have been well
characterized in existing laboratory models. Most investigation of orthopoxvirus
pathogenesis employ intravenous or intranasal infection (30, 39, 90). Intravenous
infection simulates systemic infection while intranasal infection simulates aerosolized
infection and models inoculation following natural smallpox infection or predicted
dissemination during a bioterrorist event. However the literature demonstrate that most
CPXV infections occur through contact-mediated spread within the host reservoir and to
zoonotic hosts (6, 8, 91). Previous investigations of CPXV infection in a footpad mouse
model have been limited in scope and did not examine the host response (90, 93). We
have developed a footpad model of CPXV infection in mice and have demonstrated
establishment of infection at the site of inoculation and in the draining LN, from where
secondary dissemination originates at later times. This footpad model more closely
parallels infection with orthopoxviruses such as zoonotic CPXV infection of humans,
where viral replication has been observed only at the site of infection (9). In zoonotic
CPXV infections, lymphadenopathy results from recruitment of lymphocytes to draining
LNs. In mice, CPXV footpad inoculation stimulated recruitment of many lymphocytes to
the draining LN, including NK cells, which highlights the relevance of our footpad model
for the study of in vivo CPXV infection. We have shown that our model can provide a
unique opportunity to study immune responses following inoculation with CPXV via its
natural route of infection.

NK Cells are Required for Resistance to but Not Survival of CPXV Footpad
Infection
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Immediately following infection, innate lymphocytes are recruited to the site of
infection and the draining LN. Here they stimulate an inflammatory response and
directly control infection while an adaptive immune response is primed. One innate
lymphocyte that is important at early times following infection is the NK cell, which
produces cytokines and lyses infected cells. Under homeostatic conditions, murine NK
cells are a rare LN population (74), so observation of rapid and robust expansion of NK
cell numbers in the draining LN following CPXV infection suggested that they were
important for resistance to this pathogen.
Since CPXV encodes many unique inhibitory proteins, we hypothesized that NK
cell function might be inhibited following CPXV infection. However, following systemic
NK cell depletion, CPXV replication in the draining LN was significantly increased,
indicating NK cells were functional following CPXV infection. It has been demonstrated
that splenic titers of ECTV are increased following footpad inoculation in the absence of
NK cells (81). Following inoculation with CPXV in the footpad, we observed early
spread to the lungs and the spleen in the absence of NK cells. These data demonstrate that
NK cells are important for limiting viral replication and spread following both ECTV and
CPXV infection. Therefore, we concluded that the unique inhibitory proteins of CPXV
do not completely neutralize NK cell control of replication and dissemination.
We examined the importance of NK cell control of viral replication and spread by
observing survival following CPXV infection in the NK cell depleted mice. In contrast to
previous studies using ECTV and VV which demonstrate a requirement of NK cells for
survival (80-82), depletion of NK cells prior to CPXV infection did not lead to increased
mortality. These novel findings indicate that there are differential requirements for NK
cells following orthopoxviral infections. Another possibility is that since intravenous
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inoculation was used to examine the requirement of NK cells for survival following VV
infection, it is possible that following footpad inoculation in the absence of NK cells,
lethality may not occur. It is also possible that we did not observe CPXV lethality
because the infectious dose of CPXV was too low. Dose-response experiments could be
performed examining the NK cell requirement for survival following larger infectious
doses of CPXV in the footpad model. However, high-dose inoculation following contactmediated spread within the host reservoir or to zoonotic hosts seems unlikely. We have
concluded that NK cells are important for limiting viral replication and dissemination
following CPXV infection but are not essential for survival at the dose examined.

Mechanisms of NK Cell Recruitment
Expansion of the NK cell population in the draining LN following CPXV
infection resulted from chemokine-mediated recruitment rather than in situ proliferation
of relatively rare resident cells. The role of chemokine receptor-mediated trafficking of
murine NK cells to the site of infection has been studied in the context of several
pathogens, but no commonly required chemokine receptor has been identified (64, 75, 76,
108, 140). NK cells are recruited to sites of inflammation despite expression of a variety
of inflammatory chemokines in the context of different pathogens. Therefore NK cells
must express an array of inflammatory chemokine receptors to mediate this response
(65). Additionally, expression of multiple chemokine receptors adds a protective level of
redundancy for host resistance to infection.
Previous studies have not identified specific chemokine receptors that mediate
NK cell recruitment following orthopoxvirus infection. Here we demonstrated an
intrinsic requirement for CXCR3 expression on the NK cell which mediates recruitment
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to the draining LN following CPXV infection. Meanwhile, CCR2 and CCR5, which have
been shown to be required following infection with MCMV, HSV-2, Aspergillus
fumigatus and Toxoplasma gondi (64, 75, 76, 108), were not found to be individually
necessary to mediate NK cell recruitment. While this work was in progress, it was
demonstrated that MVA, a highly attenuated orthopoxvirus, stimulates recruitment of NK
cells to draining LNs in a CXCR3-dependent and CCR5-independent manner (140),
confirming our results. Additionally, CXCR3 has been demonstrated to be responsible for
NK cell recruitment several inflammatory but non-infectious responses and for relocalization of NK cells from the red pulp to the T cell zone in the spleen following
MCMV infection (105-107, 109). CXCR3 receptor-mediated NK cell recruitment is
perhaps unsurprising, since inflammation often results in the production of IFN-! and
expression of the chemokine ligands for CXCR3 is induced by this cytokine (104). Since
a role for CXCR3 has not been examined in response to other pathogens, it may indeed
be a commonly required chemokine receptor for NK cell trafficking. Expression of
CXCR3 has been suggested as a marker of mature, cytotoxic NK cells (161), supporting
the hypothesis that CXCR3 is ubiquitously expressed on many NK cells. Therefore,
CXCR3 may be a commonly important receptor for recruitment of NK cells to sites of
inflammation and infection.
We also determined that there was a requirement for IFN-! following CPXV
infection. As discussed above, IFN-! is important for induction of inflammatory
chemokines including CXCR3. However, in the absence of CXCR3, NK cell recruitment
was decreased but not abolished. This indicated that IFN-! was also inducing other
inflammatory mediators, possibly other inflammatory chemokines. Since IFN-! is
upstream of multiple processes, only one of which is recruitment of NK cells, its role in
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mediating CXCR3-independent NK cell recruitment following CPXV infection is likely
to be complex and difficult to dissect.

A Role for DC-Mediated NK Cell Recruitment is Difficult to Ascertain
It has previously been demonstrated that footpad injection of LPS-matured DCs
results in the trafficking of DCs from the periphery to the draining LN, where they
stimulate recruitment of NK cells that produce IFN-! to prime a TH1 response (107). This
interaction, in combination with many documented interplays between NK cells and DCs
(44, 45, 53, 117), raises the possibility that DCs mediate recruitment of NK cells in
response to CPXV infection. The migration of DCs from the periphery to the draining LN
is dependent on the up-regulation of CCR7 and does not occur in mice deficient for
CCR7 (162). We did not observe NK cell recruitment to the draining LN in CCR7deficient mice, supporting the hypothesis that DCs recruit NK cells to draining LNs.
However, the LN architecture is disorganized in CCR7-deficient mice which likely leads
to defective trafficking of many lymphocytes, complicating interpretation of this
experiment (99). To further investigate the hypothesis that DCs recruit NK cells, we
examined the recruitment of migratory DCs from the periphery to the draining LN
following CPXV infection. Surprisingly, given the commonly accepted paradigm of
pathogen recognition stimulating migration of DCs from the periphery to the draining
LN, we observed comparable populations of migratory DCs in non-draining and draining
LNs. These data suggested that following CPXV footpad inoculation, DCs were not
migrating from the periphery at a greater rate or in greater numbers than under
homeostatic conditions. Additionally, while CD11c-DTR diphtheria toxin-depleted mice
showed major defects in NK cell recruitment, macrophages and other cells ectopically
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express CD11c and are depleted, confounding interpretation of these results (133, 138).
Attempts to restore DC populations in deficient systems did not result in increased NK
cell trafficking following CPXV infection. While data from several different experiments
suggest that DCs may play a role in recruitment of NK cells to the draining LN following
CPXV infection, we have been unable to establish a system that can conclusively identify
a role in NK cell recruitment. These data raise the possibility that DCs may be important,
but not sufficient for NK cell recruitment in this system.

A Novel Macrophage and NK Cell Interaction
SCS macrophages can phagocytose and detect free viral particles arriving from
the periphery through the lymphatic system (94, 129, 130). Following diphtheria toxinmediated depletion of CD11c-DTR transgenic mice, SCS macrophages were depleted,
raising the possibility that they may be required for NK cell recruitment to the draining
LN following CPXV infection (133). To test this hypothesis, we infected macrophagedepleted mice with CPXV and examined NK cell recruitment to the draining LN. Mice
that lacked macrophages in the draining LN exhibited no NK cell recruitment indicating a
novel interaction between macrophages and NK cells. During our subsequent studies,
several reports were published that also observed NK cell interactions with CD169+ SCS
macrophages and a requirement of macrophages for NK cell recruitment (131, 139, 140).
Our findings, in combination with these recently reported results, indicate a novel
interaction between macrophages and NK cells.
Macrophages can detect infection and induce inflammation, including through
production of IFN-!-induced CXCL9 and CXCL10 (134, 135). We therefore
hypothesized that macrophages mediated NK cell recruitment to the draining LN
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following CPXV infection in a CXCR3-dependent manner. However, depletion of
macrophages and subsequent CPXV infection induced comparable levels of Cxcl9 and
Cxcl10 expression as in non-depleted mice. These data indicate that macrophages recruit
NK cells in a CXCR3-independent manner. However, the mechanism of macrophagemediated NK cell recruitment is currently unknown. One possibility to explain
macrophage-mediated recruitment is that SCS macrophages are the preferentially
infected cell in the draining LN following CPXV infection, and removal of macrophages
results in diminished host recognition and therefore decreased inflammation and
lymphocyte recruitment. Another possibility is that while Cxcl9 and Cxcl10 expression
was unaffected, many viruses stimulate type I IFN production, which can lead to
expression of different chemokines such as CCL3 (77). We observed increased
expression of Ccl3 transcripts following both CPXV and VV infection, so it is possible
that macrophages induce type I IFN and mediate recruitment of NK cells through
alternate inflammatory chemokines. These data indicate that there are two, nonoverlapping pathways to recruit NK cells to the draining LN following infection,
emphasizing the importance of the expansion of the NK cell population in the draining
LN in response to viral infection.

Inappropriate Association of NK Cell Resistance and NK Cell Recruitment
NK cell-mediated resistance to ECTV infection has been inferred by the
expansion of IFN-! and granzyme B producing NK cells in the draining LN (80, 81).
However, control of ECTV in the draining LN in the presence or absence of NK cells has
not been described in the literature. Here we have demonstrated that recruitment of NK
cells was unnecessary for control of viral replication in the draining LN or spread to the
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spleen and lungs. While NK cells were essential for control of viral burden in these
organs, their specific recruitment was not necessary and rare NK cells present in the
draining LN controlled viral replication in the absence of NK cell recruitment. While this
could be a function of CPXV infection in comparison to ECTV infection, it does not
appear that expansion of the population and control of infection can be linked.

Incomplete NK Cell Maturation Despite Cytotoxic Function
When examining the maturation phenotype of NK cells isolated from the draining
LN following CPXV infection, we observed that NK cells did not produce IFN-! or upregulate some surface activation markers. This inhibition was CPXV specific and could
be overcome ex vivo by stimulating with PMA and ionomycin or in vivo by limiting the
infectious dose of CPXV during a co-infection with VV. Although CPXV inhibited NK
cell production of IFN-!, systemic depletion of NK cells resulted in increased local and
systemic viral burden. These data suggest that NK cells are partially activated following
infection and their function is likely due to production of granzyme B. Since it has been
demonstrated that stimulation of NK cells by cytokines and through activating receptors
results in different NK cell functions, CPXV may block one but not all activation signals,
resulting in this partially activated phenotype. Most infections lead to both NK cell
cytotoxicity and cytokine production, but it has been reported that following
Lymphocytic Choriomeningitis (LCMV) infection, NK cells have cytotoxic function but
do not produce IFN-! due to the lack of IL-12 induction (163). To our knowledge, no IL12 binding protein has been identified in CPXV, but it is likely that CPXV has other
mechanisms to subvert IL-12 production. It is then possible that a lack of IL-12
production may be a shared mechanism of NK cell inhibition following CPXV and
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LCMV infection. It is also possible that these systems may share additional stimulatory
and/or inhibitory signals. Thus determining shared activation and inhibition signals
during viral infection may help further understanding of differential NK cell activation
signals.
CPXV-mediated inhibition of IFN-! was multifactorial, suggesting the
involvement of both NK cell specific and non-NK cell specific virally encoded inhibitory
proteins. Partial restoration of IFN-! production by recruited NK cells was observed
following infection with the A518 mutant, CPXV&018-021 and CPXV&022-36.
CPXV018 inhibits NKG2D activation in vitro (85), but CPXV&018 did not recruit IFN-!
producing NK cells to the draining LN, suggesting an additional mechanism of IFN-!
inhibition. Induction of IFN-! production in NK cells can be stimulated by IL12, IL-15
and IL-18 and inhibited by IL-10 in the absence of IL-12 (54, 154, 164-166). CPXV
encodes an IL-18 binding protein and induces sustained high levels of IL-10 which may
non-specifically contribute to NK cell inhibition (34, 39). VV hemagglutinin expression
is recognized by NKp30 and NKp46 in HeLa cells, resulting in NK cell inhibition (167169). The ability of CPXV hemagglutinin to bind these natural cytotoxicity receptors has
not been examined, but it is possible that CPXV also mediates NK cell inhibition through
this mechanism. The numerous CPXV inhibitory proteins and their individual and
synergistic effects on the host response clearly confer a strong advantage to CPXV during
infection of the host, but will also complicate any attempt to discern individual
contributions of each inhibitory protein to CPXV immune evasion.
Although NK cells did not produce IFN-! following CPXV infection, increased
viral burden following systemic NK cell depletion indicated that NK cells were an
important component of the host response. Additionally, given the number of viral
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inhibitory proteins that directly or indirectly impact NK cell activation, it must be
advantageous for CPXV to even partially inhibit NK cell function. It is interesting to
speculate about the ability of CPXV to infect and disseminate within the host in the
context of uninhibited NK cell activation. Several experiments could be designed to
overcome the in vivo inhibition of NK cells. The importance of IL-12 and IL-18 for NK
cell activation has been demonstrated following ECTV and VV suggesting they might
also be important following CPXV infection (41, 42). Since inhibition may occur through
or be modulated by virally encoded cytokine binding proteins, treatment with IL-12
and/or IL-18 or infection with CPXV which recombinantly expresses either cytokine
could result in saturation of virally encoded cytokine binding proteins, allowing NK cell
activation. Another way to restore NK cell functionality might be examine NK cell
activation following infection with the CPXV&018 mutant. Although our studies have
demonstrated that lack of CPXV018 does not restore IFN-! production, it is possible that
CPXV018 may also inhibit cytotoxic NK cell function. Inhibition of NK cell function
may be essential for establishment CPXV infection and dissemination within the host.
These proposed experiments may help dissect the reason CPXV encodes many inhibitory
proteins against NK cell function.
Aside from cytotoxicity and stimulation of inflammation, NK cell production of
IFN-! also shapes the TH1 response (107). It is possible that priming of the adaptive
immune response is delayed following CPXV infection in comparison to VV or ECTV
infection in the absence of NK cell produced IFN-!. The scope of these studies did not
include an examination of this process, but systemic depletion of NK cells did result in
delayed viral clearance in the draining LN and the foot, suggesting a delay in the adaptive
immune response. Therefore, CPXV inhibition of IFN-! may be beneficial for both
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suppressing NK lysis of CPXV infected cells and delaying the priming of a TH1 response,
resulting in prolonged CPXV infection.

Clinical Relevance
Many studies use members of the orthopoxvirus genus to model smallpox virus
infection, but symptoms, viral spread and disease course vary greatly between these
orthopoxviruses. Despite the lack of lethality following CPXV infection in the mouse
model, footpad infection of mice closely mimics zoonotic infection making it a relevant
model to study vacciniation and zoonotic infection following a range of non-lethal
orthopoxvirus infections. Vaccination of patients that are immunocompromised or have
atopic dermatitis is not advised, but with increasing numbers of emerging and zoonotic
poxvirus infections, safer vaccine development is crucial. Many strategies have been
employed to generate new vaccines, including directed deletion of inhibitory proteins.
Since NK cells are important for limiting early viral replication, inducing inflammation
and priming the adaptive immune response, removal of virally encoded NK cell specific
and non-NK cell specific inhibitors from novel candidate vaccine strains is important.
Conversely, in inflammatory diseases where NK cells are inappropriately activated,
identification of virally encoded NK cell specific inhibitors may be a useful therapeutic
treatment.

Concluding Remarks
Studies examining the host response to viral infection and viral immune evasion
provide insight into the complexity of host-pathogen interaction. In these studies, we
have demonstrated the relevance of studying CPXV in a footpad model of infection to
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further characterize and understand zoonotic orthopoxvirus infections. We have
highlighted the importance of NK cells following CPXV infection, studied the
mechanism of NK cell recruitment in the context of natural infection and the complicated
and multifactorial nature of viral inhibition of NK cell function. Further investigation will
help illuminate and dissect these intricate host-pathogen interactions.
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